<SEC-DOCUMENT>0001193125-22-228841.txt : 20221031
<SEC-HEADER>0001193125-22-228841.hdr.sgml : 20221031
<ACCEPTANCE-DATETIME>20220824205035
ACCESSION NUMBER:		0001193125-22-228841
CONFORMED SUBMISSION TYPE:	POS EX
PUBLIC DOCUMENT COUNT:		16
FILED AS OF DATE:		20220825
DATE AS OF CHANGE:		20220824
EFFECTIVENESS DATE:		20220825

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ELLSWORTH GROWTH & INCOME FUND LTD
		CENTRAL INDEX KEY:			0000793040
		IRS NUMBER:				133345139
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		POS EX
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-248511
		FILM NUMBER:		221192747

	BUSINESS ADDRESS:	
		STREET 1:		65 MADISON AVENUE
		STREET 2:		SUITE 550
		CITY:			MORRISTOWN
		STATE:			NJ
		ZIP:			07960
		BUSINESS PHONE:		(973) 631-1177

	MAIL ADDRESS:	
		STREET 1:		65 MADISON AVE
		STREET 2:		SUITE 550
		CITY:			MORRISTOWN
		STATE:			NJ
		ZIP:			07960

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ELLSWORTH FUND LTD
		DATE OF NAME CHANGE:	20060330

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ELLSWORTH CONVERTIBLE GROWTH & INCOME FUND INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>POS EX
<SEQUENCE>1
<FILENAME>d396220dposex.htm
<DESCRIPTION>ELLSWORTH GROWTH & INCOME FUND LTD
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:cik0000793040="http://www.gabelli.com/20220824" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:cef="http://xbrl.sec.gov/cef/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>ELLSWORTH GROWTH &amp;amp; INCOME FUND LTD</title>
<meta content="text/html; charset=UTF-8" http-equiv="Content-Type"/>
</head>
<body><div style="display: none"><ix:header><ix:hidden><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="P08_24_2022To08_24_2022">0000793040</ix:nonNumeric><ix:nonNumeric name="dei:AmendmentFlag" contextRef="P08_24_2022To08_24_2022">false </ix:nonNumeric><ix:nonNumeric name="dei:DocumentType" contextRef="P08_24_2022To08_24_2022">POS EX</ix:nonNumeric><ix:nonNumeric name="dei:EntityWellKnownSeasonedIssuer" id="hidden55199683" contextRef="P08_24_2022To08_24_2022">No</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="cik0000793040-20220824.xsd"/><link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="cik0000793040-20220824_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/><link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="cik0000793040-20220824_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/><link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="cik0000793040-20220824_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/></ix:references><ix:resources><xbrli:context id="P08_24_2022To08_24_2022"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000793040</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-08-24</xbrli:startDate> <xbrli:endDate>2022-08-24</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P08_24_2022To08_24_2022_BusinessContactMemberdeiEntityAddressesAddressTypeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000793040</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-08-24</xbrli:startDate> <xbrli:endDate>2022-08-24</xbrli:endDate> </xbrli:period> </xbrli:context></ix:resources></ix:header></div><div style="background-color:white;display: inline;"><div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">As filed with the Securities and Exchange Commission on August 24, 2022 </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:right">Securities Act File No.&#160;333-248511 </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:right">Investment Company Act File No.&#160;811-04656 </div></div><div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div><div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div><div style="margin-top:4pt; margin-bottom:0pt; font-size:13pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:13pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, DC 20549 </div><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:13pt; font-family:Times New Roman;font-weight:bold;text-align:center">Form <div style="white-space:nowrap;display:inline;">N-2</div> </div><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div style="margin-top:2pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:center"><div style="font-weight:bold;display:inline;">(Check Appropriate Box or Boxes) </div><div style="font-weight:bold;display:inline;"> </div></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:2%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:97%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#9746;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><div style="font-weight:bold;display:inline;">REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933</div></td></tr>
<tr style="font-size:1pt">
<td style="height:1.5pt"/>
<td colspan="2" style="height:1.5pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#9744;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><div style="font-weight:bold;display:inline;"><div style="white-space:nowrap;display:inline;">Pre-Effective</div> Amendment No.</div></td></tr>
<tr style="font-size:1pt">
<td style="height:1.5pt"/>
<td colspan="2" style="height:1.5pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#9746;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><div style="font-weight:bold;display:inline;">Post-Effective Amendment No.&#160;1</div></td></tr></table></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">and/or </div><div style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:2%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:97%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#9746;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><div style="font-weight:bold;display:inline;">REGISTRATION STATEMENT UNDER THE INVESTMENT COMPANY ACT OF 1940</div></td></tr>
<tr style="font-size:1pt">
<td style="height:1.5pt"/>
<td colspan="2" style="height:1.5pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">&#9746;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><div style="font-weight:bold;display:inline;">Amendment No.&#160;18</div></td></tr></table></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div><div style="margin-top:0pt; margin-bottom:0pt; font-size:19pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="P08_24_2022To08_24_2022">Ellsworth Growth and Income Fund Ltd.</ix:nonNumeric> </div></div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of Registrant as specified in Charter) </div><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div style="margin-top:2pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="P08_24_2022To08_24_2022">One Corporate Center</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="P08_24_2022To08_24_2022">Rye</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="P08_24_2022To08_24_2022" format="ixt-sec:stateprovnameen">New York</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="P08_24_2022To08_24_2022">10580-1422</ix:nonNumeric> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of Principal Executive Offices) </div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s Telephone Number, including Area Code: (<ix:nonNumeric name="dei:CityAreaCode" contextRef="P08_24_2022To08_24_2022">800</ix:nonNumeric>) <div style="white-space:nowrap;display:inline;"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="P08_24_2022To08_24_2022">422-3554</ix:nonNumeric></div> </div><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div><div style="margin-top:2pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:ContactPersonnelName" contextRef="P08_24_2022To08_24_2022_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">James A. Dinsmore</ix:nonNumeric> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Ellsworth Growth and Income Fund Ltd. </div></div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="P08_24_2022To08_24_2022_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">One Corporate Center</ix:nonNumeric> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="P08_24_2022To08_24_2022_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">Rye</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="P08_24_2022To08_24_2022_BusinessContactMemberdeiEntityAddressesAddressTypeAxis" format="ixt-sec:stateprovnameen">New York</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="P08_24_2022To08_24_2022_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">10580-1422</ix:nonNumeric> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(914) <div style="white-space:nowrap;display:inline;">921-5100</div> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Name and Address of Agent for Service) </div><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div style="margin-top:2pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center"><div style="font-style:italic;display:inline;">Copies to: </div></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:48%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;text-align:center;"><div style="font-weight:bold;display:inline;">Peter Goldstein, Esq.</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center;"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Thomas A. DeCapo, Esq.</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Kenneth E. Burdon, Esq.</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center;"><div style="font-weight:bold;display:inline;">Ellsworth Growth and Income Fund Ltd.</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center;"><div style="font-weight:bold;display:inline;">Skadden,&#160;Arps,&#160;Slate,&#160;Meagher&#160;&amp;&#160;Flom&#160;LLP</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center;"><div style="font-weight:bold;display:inline;">One Corporate Center</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center;"><div style="font-weight:bold;display:inline;">500 Boylston Street</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center;"><div style="font-weight:bold;display:inline;">Rye, New York 10580-1422</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center;"><div style="font-weight:bold;display:inline;">Boston, Massachusetts 02116</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center;"><div style="font-weight:bold;display:inline;">(914) <div style="white-space:nowrap;display:inline;">921-5100</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center;"><div style="font-weight:bold;display:inline;">(617) <div style="white-space:nowrap;display:inline;">573-4800</div></div></td></tr></table></div><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><div style="font-weight:bold;display:inline;">Approximate Date of Commencement of Proposed Public Offering:</div> From time to time after the effective date of this Registration Statement. </div><div style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#9744;</td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">Check box if the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans. </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#9745;</td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">Check box if any securities being registered on this Form will be offered on a delayed or continuous basis in reliance on Rule 415 under the Securities Act of 1933 (&#8220;Securities Act&#8221;), other than securities offered in connection with a dividend reinvestment plan. </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#9745;</td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">Check box if this Form is a registration statement pursuant to General Instruction A.2 or a post-effective amendment thereto. </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#9744;</td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">Check box if this Form is a registration statement pursuant to General Instruction B or a post-effective amendment thereto that will become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act. </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#9744;</td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">Check box if this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction B to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act. </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">It is proposed that this filing will become effective (check appropriate box): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#9744;</td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">when declared effective pursuant to section 8(c) of the Securities Act </div></td></tr></table><div style="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">If appropriate, check the following box: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#9744;</td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">This [post-effective] amendment designates a new effective date for a previously filed [post-effective amendment] [registration statement]. </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#9744;</td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">This Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, and </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">the Securities Act registration statement number of the earlier effective registration statement for the same offering is: ______. </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;"><ix:nonNumeric name="dei:NoSubstantiveChanges462c" contextRef="P08_24_2022To08_24_2022" format="ixt:fixed-false">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">This Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, and the Securities Act </div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">registration statement number of the earlier effective registration statement for the same offering is: ______. </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;"><ix:nonNumeric name="dei:ExhibitsOnly462d" contextRef="P08_24_2022To08_24_2022" format="ixt:fixed-true">&#9746;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">This Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, and the Securities Act </div></td></tr></table><div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#160;</td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">registration statement number of the earlier effective registration statement for the same offering is: 333-248511. </div></td></tr></table></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Check each box that appropriately characterizes the Registrant: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#9745;</td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">Registered <div style="white-space:nowrap;display:inline;">Closed-End</div> Fund <div style="white-space:nowrap;display:inline;">(closed-end</div> company that is registered under the Investment Company Act of 1940 (the &#8220;Investment Company Act&#8221;)). </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#9744;</td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">Business Development Company <div style="white-space:nowrap;display:inline;">(closed-end</div> company that intends or has elected to be regulated as a business development company under the Investment Company Act. </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#9744;</td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">Interval Fund (Registered <div style="white-space:nowrap;display:inline;">Closed-End</div> Fund or a Business Development Company that makes periodic repurchase offers under Rule <div style="white-space:nowrap;display:inline;">23c-3</div> under the Investment Company Act). </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#9745;</td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">A.2 Qualified (qualified to register securities pursuant to General Instruction A.2 of this Form). </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;"><span style="-sec-ix-hidden:hidden55199683">&#9744;</span></td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">Well-Known Seasoned Issuer (as defined by Rule 405 under the Securities Act). </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;"><ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="P08_24_2022To08_24_2022" format="ixt:fixed-false">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">Emerging Growth Company (as defined by Rule <div style="white-space:nowrap;display:inline;">12b-2</div> under the Securities and Exchange Act of 1934). </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#9744;</td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">If an Emerging Growth Company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;7(a)(2)(B) of the Securities Act. </div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;border:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left;">&#9744;</td>
<td style="vertical-align:top;text-align:left;"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;text-align:left">New Registrant (registered or regulated under the Investment Company Act for less than 12 calendar months preceding this filing). </div></td></tr></table></div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
 <div> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">EXPLANATORY NOTE </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Post-Effective Amendment No. 1 to the Registration Statement on Form N-2 (File No. 333-248511) of Ellsworth Growth and Income Fund Ltd. (the &#8220;Registration Statement&#8221;) is being filed pursuant to Rule 462(d) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), solely for the purpose of filing exhibits to the Registration Statement. Accordingly, this Post-Effective Amendment No. 1 consists only of a facing page, this explanatory note and Part C of the Registration Statement on Form N-2 setting forth the exhibits to the Registration Statement. This Post-Effective Amendment No. 1 does not modify any other part of the Registration Statement. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to Rule 462(d) under the Securities Act, this Post-Effective Amendment No. 1 shall become effective immediately upon filing with the Securities and Exchange Commission. The contents of the Registration Statement are hereby incorporated by reference. </p> </div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
 <div> </div> <div> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">PART C </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">OTHER INFORMATION </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;25.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Financial&#160;Statements </p></td></tr></table> <p style="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Part A </p> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><a href="http://www.sec.gov/Archives/edgar/data/0001585855/000138713122003413/ggz-ncsr_123121.htm">The audited financial statements included in the annual report to the Fund&#8217;s shareholders for the fiscal year ended September&#160;30, 2021 (the &#8220;2021 Annual Report&#8221;), together with the report of PricewaterhouseCoopers LLP thereon, are incorporated by reference to the 2021 Annual Report in Part A. </a> </p> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><a href="http://www.sec.gov/Archives/edgar/data/793040/000119312519305953/d810584dncsr.htm">The audited financial statements included in the annual report to the Fund&#8217;s shareholders for the fiscal year ended September&#160;30, 2019 (the &#8220;2019 Annual Report&#8221;), together with the report of PricewaterhouseCoopers LLP thereon, are incorporated by reference to the 2019 Annual Report in Part A.</a> </p> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><a href="http://www.sec.gov/Archives/edgar/data/793040/000119312517364851/d450367dncsr.htm">The report of Tait, Weller&#160;&amp; Baker LLP included in the annual report to the Fund&#8217;s shareholders for the fiscal year ended September&#160;30, 2017 (the &#8220;2017 Annual Report&#8221;), is incorporated by reference to the 2017 Annual Report in Part A.</a> </p> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><a href="http://www.sec.gov/Archives/edgar/data/793040/000138713122006747/ecf-ncsrs_033122.htm">The unaudited financial statements included in the semi-annual report to the Fund&#8217;s shareholders for the six months ended March&#160;31, 2022 are incorporated by reference to the Fund&#8217;s semi-annual report to shareholders in Part A.</a> </p> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><a href="http://www.sec.gov/Archives/edgar/data/793040/000114544314001460/d31894.htm">The Financial Highlights included in the annual report to the Fund&#8217;s shareholders for the fiscal year ended September&#160;30, 2014 (the &#8220;2014 Annual Report&#8221;), are incorporated by reference to the 2014 Annual Report in Part A.</a> </p> <p style="margin-top:18pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Part B </p> <p style="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">None </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(2)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Exhibits </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(a)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><a href="http://www.sec.gov/Archives/edgar/data/793040/000079304006000010/ex77q1a.txt">(i) &#160;&#160;Amended and Restated Agreement and Declaration of Trust of Registrant(1)</a> </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman"><a href="http://www.sec.gov/Archives/edgar/data/793040/000119312517229401/d413288dex99aii.htm">(ii) &#160;Amendment No.&#160;1 to Amended and Restated Agreement and Declaration of Trust of Registrant(2)</a> </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman"><a href="http://www.sec.gov/Archives/edgar/data/793040/000119312517229401/d413288dex99aiii.htm">(iii) Amendment No.&#160;2 to Amended and Restated Agreement and Declaration of Trust of Registrant(2)</a> </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman"><a href="http://www.sec.gov/Archives/edgar/data/793040/000134100417000591/ex_aiv.htm">(iv) Statement of Preferences for 5.25% Series A&#160;Cumulative Preferred Shares(7)</a> </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(v) &#160;<a href="d396220dex99av.htm">Statement of Preferences for Series B Cumulative Preferred Shares ** </a> </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(v) &#160;Statement of Preferences for &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Cumulative Preferred Shares * </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(b)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">(i)<a href="http://www.sec.gov/Archives/edgar/data/793040/000094040016001146/ellsworth77q11.txt"> &#160;&#160;Amended and <span style="white-space:nowrap">Restated&#160;By-Laws&#160;of</span> Registrant(3)</a> </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman"><a href="d396220dex99bii.htm">(ii) &#160;Amendment No.&#160;1 to Amended and Restated <span style="white-space:nowrap">By-Laws</span> of Registrant ** </a> </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(c)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Not applicable </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(d)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">(i) &#160;&#160;Form of Subscription Certificate for Common Shares * </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(ii) &#160;Form of Subscription Certificate for [&#160;&#160;&#160;&#160;]% Series &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Cumulative Preferred Shares * </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(iii) Form of Subscription Certificate Shares for Common Shares and [&#160;&#160;&#160;&#160;]% Series &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Cumulative Preferred &#160;&#160;&#160;&#160;&#160;&#160;&#160;Shares * </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman"><a href="http://www.sec.gov/Archives/edgar/data/793040/000119312520236391/d83896dex99div.htm">(iv) Form of Indenture (9)</a> </p> </div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
 <div> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(v) <span style="white-space:nowrap">&#160;Form&#160;T-1&#160;Statement</span> of Eligibility of Trustee with respect to the Form of Indenture * </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(e)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">AutomaticDividend Reinvestment and Voluntary Cash Purchase Plans of Registrant(4) </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(f)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Not applicable </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(g)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><a href="http://www.sec.gov/Archives/edgar/data/793040/000094040016001146/ellsworth77q12.txt">Investment Advisory Agreement between Registrant and Gabelli Funds, LLC(3)</a> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(h)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">(i) &#160;&#160;Form of Underwriting Agreement * </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(ii) &#160;Form of Dealer Manager Agreement * </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(i)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Not applicable </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(j)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><a href="http://www.sec.gov/Archives/edgar/data/1087966/000093506902000394/exhg.txt">(i) &#160;&#160;Amended and Restated Master Custodian Agreement, dated July&#160;2, 2001, between the Registrant, by amended appendix, and State Street Bank&#160;&amp; Trust Company(5)</a> </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman"><a href="http://www.sec.gov/Archives/edgar/data/793040/000119312517229401/d413288dex99jii.htm">(ii) &#160;Revised Schedule A to Master Custodian Agreement(2)</a> </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(k)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><a href="http://www.sec.gov/Archives/edgar/data/793040/000079304003000015/ecf-2003_exhibitk1.txt">(i) &#160;&#160;Registrar, Transfer Agency and Service Agreement, dated January&#160;3, 2002, between Registrant and American Stock Transfer&#160;&amp; Trust Company, LLC(6)</a> </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman"><a href="http://www.sec.gov/Archives/edgar/data/793040/000134100417000591/ex_kii.htm">(ii) &#160;Addendum to Registrar, Transfer Agency and Services Agreement (7)</a> </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(iii) Form of Rights Agent Agreement * </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(iv) Form of Information Agent Agreement * </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(l)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><a href="http://www.sec.gov/Archives/edgar/data/9521/000119312521356879/d230096dex99i.htm">Opinion and Consent of Skadden, Arps, Slate, Meagher&#160;&amp; Flom LLP with respect to legality (10)</a> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(m)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Not applicable </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(n)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">(i) &#160;&#160;Consent of Independent Registered Public Accounting Firm (10) </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(ii) &#160;<a href="http://www.sec.gov/Archives/edgar/data/9521/000119312521356879/d230096dex99nii.htm">Consent of Independent Registered Public Accounting Firm (10)</a> </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">(iii) Consent of Independent Registered Public Accounting Firm (11) </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(o)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Not applicable </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(p)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Not applicable </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(q)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Not applicable </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(r)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><a href="http://www.sec.gov/Archives/edgar/data/793040/000119312520004758/d851351dex99r.htm">Code&#160;of Ethics of the Fund and the Investment Adviser(8)</a> </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(s)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><a href="http://www.sec.gov/Archives/edgar/data/793040/000119312520236391/d83896dex99si.htm">(i) &#160;&#160;&#160;Powers of Attorney (9)</a> </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman"><a href="http://www.sec.gov/Archives/edgar/data/793040/000119312520236391/d83896dex99sii.htm">(ii) &#160;&#160;Form of Prospectus Supplement Relating to Common Shares (9)</a> </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman"><a href="http://www.sec.gov/Archives/edgar/data/793040/000119312520236391/d83896dex99siii.htm">(iii) &#160;Form of Prospectus Supplement Relating to Preferred Shares (9)</a> </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman"><a href="http://www.sec.gov/Archives/edgar/data/793040/000119312520236391/d83896dex99siv.htm">(iv) &#160;Form of Prospectus Supplement Relating to Notes (9)</a> </p> </div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
 <div> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman"><a href="http://www.sec.gov/Archives/edgar/data/793040/000119312520236391/d83896dex99sv.htm">(v) &#160;&#160;Form of Prospectus Supplement Relating to Subscription Rights to Purchase Common Shares (9)</a> </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman"><a href="http://www.sec.gov/Archives/edgar/data/793040/000119312520236391/d83896dex99svi.htm">(vi) &#160;Form of Prospectus Supplement Relating to Subscription Rights to Purchase Preferred Shares (9)</a> </p> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman"><a href="http://www.sec.gov/Archives/edgar/data/793040/000119312520236391/d83896dex99svii.htm">(vii) Form of Prospectus Supplement Relating to Subscription Rights to Purchase Common and Preferred Shares (9)</a> </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Incorporated by reference to the Registrant&#8217;s <span style="white-space:nowrap">Form&#160;N-SAR,&#160;filed</span> with the Commission on May&#160;30, 2006. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left">(2)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Incorporated by reference to the Registrant&#8217;s Registration Statement on <span style="white-space:nowrap"><span style="white-space:nowrap">Form&#160;N-2,&#160;File&#160;No.&#160;333-219322,&#160;as</span></span> filed with the Commission on July&#160;17, 2017. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left">(3)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Incorporated by reference to the Registrant&#8217;s <span style="white-space:nowrap">Form&#160;N-SAR,&#160;filed</span> with the Commission on May&#160;24, 2016. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left">(4)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Included in Prospectus. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left">(5)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Incorporated&#160;by&#160;reference&#160;to&#160;Exhibit&#160;(g)&#160;of&#160;The&#160;Gabelli&#160;Utilities&#160;Fund&#8217;s Registration Statement on <span style="white-space:nowrap">Form&#160;N-1A,&#160;File</span> <span style="white-space:nowrap"><span style="white-space:nowrap">Nos.&#160;333-81209&#160;and&#160;811-09397,&#160;as</span></span> filed with the Commission on May&#160;1, 2002. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left">(6)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Incorporated by reference to the Registrant&#8217;s Registration Statement on <span style="white-space:nowrap"><span style="white-space:nowrap">Form&#160;N-2,&#160;File&#160;No.&#160;333-108694,&#160;as</span></span> filed with the Commission on September&#160;11, 2003. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left">(7)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Incorporated by reference to Post-Effective Amendment No.&#160;1 to the Registrant&#8217;s Registration Statement on <span style="white-space:nowrap"><span style="white-space:nowrap">Form&#160;N-2,&#160;File&#160;No.&#160;333-219322,&#160;as</span></span> filed with the Commission on September&#160;14, 2017. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left">(8)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Incorporated by reference to Post-Effective Amendment No.&#160;2 to the Registrant&#8217;s Registration Statement on <span style="white-space:nowrap"><span style="white-space:nowrap">Form&#160;N-2,&#160;File&#160;No.&#160;333-219322,&#160;as</span></span> filed with the Commission on January&#160;9, 2020. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left">(9)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Incorporated by reference to the Registrant&#8217;s Registration Statement on Form <span style="white-space:nowrap">N-2,</span> File <span style="white-space:nowrap">No.&#160;333-248511,</span> as filed with the Commission on August&#160;31, 2020. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left">(10)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Incorporated by reference to the Registrant&#8217;s <span style="white-space:nowrap">Pre-Effective</span> Amendment No.&#160;1 to the Registration Statement on Form <span style="white-space:nowrap">N-2,</span> File Nos. <span style="white-space:nowrap">333-248511</span> and <span style="white-space:nowrap">811-04656,</span> as filed with the Securities and Exchange Commission on November&#160;20, 2020. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left">(11)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Incorporated by reference to the Registrant&#8217;s Annual Report on Form <span style="white-space:nowrap">N-CSR</span> for the fiscal year ended September&#160;30, 2021, as filed with the Securities and Exchange Commission on December&#160;3, 2021 </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left">*</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">To be filed by Amendment. </p></td></tr></table>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:5%;vertical-align:top" align="left">**</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Filed herewith. </p></td></tr></table> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;26.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Marketing Arrangements </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The information contained under the heading &#8220;Plan of Distribution&#8221; on page 77 of the Prospectus is incorporated by reference, and any information concerning any underwriters will be contained in the accompanying Prospectus Supplement, if any. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;27.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Other Expenses of Issuance and Distribution </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth the estimated expenses to be incurred in connection with the offering described in this Registration Statement: </p> </div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:60%;border:0;margin:0 auto">


<tr>

<td style="width:92%"/>

<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SEC registration fees</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">12,980</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">NYSE American listing fee</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">28,394</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rating Agency fees</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">50,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Printing/engraving expenses</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">150,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounting fees and expenses</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">47,500</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Legal fees and expenses</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">315,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">FINRA fees</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">15,500</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Miscellaneous</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">95,626</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1px">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&#160;</p></td>
<td>&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">$</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">715,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> </div> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;28.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Persons Controlled by or Under Common Control with Registrant </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">None. </p> </div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
 <div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;29.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Number of Holders of Securities as of August&#160;[&#160;&#160;&#160;&#160;], 2022: </p></td></tr></table> </div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:70%;border:0;margin:0 auto">


<tr>

<td style="width:89%"/>

<td style="vertical-align:bottom;width:8%"/>
<td style="width:26pt"/>
<td/>
<td/>
<td style="width:26pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Class&#160;of Shares</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="4" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Number&#160;of</span><br/><span style="font-weight:bold">Record&#160;Holders</span></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common Shares</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">278</td>
<td style="white-space:nowrap;vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series B Preferred</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">23</td>
<td style="white-space:nowrap;vertical-align:bottom"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series A Cumulative Preferred Shares</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1</td>
<td style="white-space:nowrap;vertical-align:bottom"/></tr>
</table> </div> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;30.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Indemnification </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">The Registrant&#8217;s Amended and Restated Agreement and Declaration of Trust provides as follows</span>: </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&#160;1.2(g). Definitions. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#8220;Covered Person&#8221; means a person who is or was a Trustee, officer, employee or agent of the Trust, or is or was serving at the request of the Trustees as a director, trustee, partner, officer, employee or agent of a corporation, trust, partnership, joint venture or other enterprise </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&#160;2.8 Personal Liability of Shareholders. Neither the Trust nor the Trustees, nor any officer, employee, or agent of the Trust shall have any power to bind personally any Shareholder or to call upon any Shareholder for the payment of any sum of money or assessment whatsoever other than such as the Shareholder may at any time personally agree to pay by way of subscription for any Shares or otherwise. The Shareholders shall be entitled, to the fullest extent permitted by applicable law, to the same limitation of personal liability as is extended under the Delaware General Corporation Law to stockholders of private corporations for profit. Every note, bond, contract or other undertaking issued by or on behalf of the Trust or the Trustees relating to the Trust shall include a recitation limiting the obligation represented thereby to the Trust and the assets belonging thereto (but the omission of such a recitation shall not operate to bind any Shareholder or Trustee of the Trust or otherwise limit any benefits set forth in the Delaware Act that may be applicable to such Persons). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&#160;8.2. Indemnification of Covered Persons. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Every Covered Person shall be indemnified by the Trust to the fullest extent permitted by the Delaware Act, the Bylaws and other applicable law. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&#160;8.3. Indemnification of Shareholders. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In case any Shareholder or former Shareholder of the Trust shall be held to be personally liable solely by reason of his being or having been a Shareholder of the Trust or any Class&#160;and not because of his acts or omissions or for some other reason, the Shareholder or former Shareholder (or his heirs, executors, administrators or other legal representatives, or, in the case of a corporation or other entity, its corporate or general successor) shall be entitled, out of the assets of the Trust, to be held harmless from and indemnified against all loss and expense arising from such liability in accordance with the Bylaws and applicable law. The Trust shall upon request by the Shareholder, assume the defense of any such claim made against the Shareholder for any act or obligation of the Trust. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Article VII of the Registrant&#8217;s Amended and Restated Bylaws provides: </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&#160;6.1. Mandatory Indemnification. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) The Fund shall indemnify the Trustees and officers of the Fund (each such person being an &#8220;indemnitee&#8221;) against any liabilities and expenses, including amounts paid in satisfaction of judgments, in compromise or as fines and penalties, and reasonable counsel fees reasonably incurred by such indemnitee in connection with the defense or disposition of any action, suit or other proceeding, whether civil or criminal, before any court or administrative or investigative body in which he may be or may have been involved as a party or otherwise (other than, except as authorized by the Trustees, as the plaintiff or complainant) or with which he may be or may have been threatened, while acting in any capacity set forth above in this Section&#160;6.1 by reason of his having acted in any such capacity, except with respect to any matter as to which he shall not have acted in good faith in the reasonable belief that his action was in the best interest of the Fund or, in the case of any criminal proceeding, as to which he shall have had reasonable cause to believe that the conduct was unlawful, provided, however, that no indemnitee shall be </p> </div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
 <div> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
indemnified hereunder against any liability to any person or any expense of such indemnitee arising by reason of (1)&#160;willful misfeasance, (2)&#160;bad faith, (3)&#160;gross negligence, or (4)&#160;reckless disregard of the duties involved in the conduct of his position (the conduct referred to in such clauses (1)&#160;through (4)&#160;being sometimes referred to herein as &#8220;disabling conduct&#8221;). Notwithstanding the foregoing, with respect to any action, suit or other proceeding voluntarily prosecuted by any indemnitee as plaintiff, indemnification shall be mandatory only if the prosecution of such action, suit or other proceeding by such indemnitee was authorized by a majority of the Trustees. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding the foregoing, no indemnification shall be made hereunder unless there has been a determination (i)&#160;by a final decision on the merits by a court or other body of competent jurisdiction before whom the issue of entitlement to indemnification hereunder was brought that such indemnitee is entitled to indemnification hereunder or, (ii)&#160;in the absence of such a decision, by (1)&#160;a majority vote of a quorum of those Independent Trustees who are not parties to the proceeding <span style="white-space:nowrap">(&#8220;Disinterested&#160;Non-Party&#160;Trustees&#8221;),</span> that the indemnitee is entitled to indemnification hereunder, or (2)&#160;if such quorum is not obtainable or even if obtainable, if such majority so directs, independent legal counsel in a written opinion conclude that the indemnitee should be entitled to indemnification hereunder. All determinations to make advance payments in connection with the expense of defending any proceeding shall be authorized and made in accordance with the immediately succeeding paragraph (c)&#160;below. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c) The Fund shall make advance payments in connection with the expenses of defending any action with respect to which indemnification might be sought hereunder if the Fund receives a written affirmation by the indemnitee of the indemnitee&#8217;s good faith belief that the standards of conduct necessary for indemnification have been met and a written undertaking to reimburse the Fund unless it is subsequently determined that he is entitled to such indemnification and if a majority of the Trustees determine that the applicable standards of conduct necessary for indemnification appear to have been met. In addition, at least one of the following conditions must be met: (i)&#160;the indemnitee shall provide adequate security for his undertaking, (ii)&#160;the Fund shall be insured against losses arising by reason of any lawful advances, or (iii)&#160;a majority of a quorum of the <span style="white-space:nowrap">Disinterested&#160;Non-Party&#160;Trustees,</span> or if a majority vote of such quorum so direct, independent legal counsel in a written opinion, shall conclude, based on a review of readily available facts (as opposed to a full trial-type inquiry), that there is substantial reason to believe that the indemnitee ultimately will be found entitled to indemnification. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) The rights accruing to any indemnitee under these provisions shall not exclude any other right to which he may be lawfully entitled. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(e) Notwithstanding the foregoing, subject to any limitations provided by the 1940 Act, the Declaration and <span style="white-space:nowrap">these&#160;By-Laws,&#160;the</span> Fund shall have the power and authority to indemnify persons providing services to the Fund to the full extent provided by law as if the Fund were a corporation organized under the Delaware General Corporation Law provided that such indemnification (or contractual provision therefor) has been approved by a majority of the Trustees. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&#160;6.2 No Duty of Investigation; Notice in Fund Instruments, etc. No purchaser, lender, transfer agent or other person dealing with the Trustees or with any officer, employee or agent of the Fund shall be bound to make any inquiry concerning the validity of any transaction purporting to be made by the Trustees or by said officer, employee or agent or be liable for the application of money or property paid, loaned, or delivered to or on the order of the Trustees or of said officer, employee or agent. Every obligation, contract, undertaking, instrument, certificate, Share, other security of the Trust, and every other act or thing whatsoever executed in connection with the Fund shall be conclusively taken to have been executed or done by the executors thereof only in their capacity as Trustees under these <span style="white-space:nowrap">By-Laws</span> or in their capacity as officers, employees or agents of the Trust. The Trustees may maintain insurance for the protection of the Fund Property, its shareholders, Trustees, officers, employees and agents in such amount as the Trustees shall deem adequate to cover possible liability, and such other insurance as the Trustees in their sole judgment shall deem advisable or is required by the 1940 Act. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&#160;6.3. Reliance on Experts, etc. Each Trustee and officer or employee of the Fund shall, in the performance of its duties, be fully and completely justified and protected with regard to any act or any failure to act resulting from reliance in good faith upon the books of account or other records of the Trust, upon an opinion of counsel, or upon reports made to the Fund by any of the Fund&#8217;s officers or employees or by any advisor, administrator, manager, distributor, selected dealer, accountant, appraiser or other expert or consultant selected with reasonable care by the Trustees, officers or employees of the Fund, regardless of whether such counsel or other person may also be a Trustee. </p> </div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
 <div> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Section&#160;6.4 Amendment, Repeal or Modification. Any amendment, repeal, or modification of, or adoption of any provision inconsistent with, this Article VI (or any provision hereof) shall not adversely affect any right to indemnification or advancement of expenses granted to any person pursuant hereto with respect to any act or omission of such person occurring prior to the time of such amendment, repeal, modification, or adoption (regardless of whether the proceeding relating to such acts or omissions is commenced before or after the time of such amendment, repeal, modification, or adoption). Any amendment or modification of, or adoption of any provision inconsistent with, this Article VI (or any provision hereof), that has the effect of positively affecting any right to indemnification or advancement of expenses granted to any person pursuant hereto, shall not apply retroactively to any person who was not serving as a Trustee or officer of the Fund at the time of such amendment, modification or adoption. The provisions of this Article VI do not deprive any person who was a Covered Person at the time of the adoption of <span style="white-space:nowrap">these&#160;By-Laws&#160;of</span> any benefit provided under the Fund&#8217;s Amended and <span style="white-space:nowrap">Restated&#160;By-Laws,&#160;effective</span> as of April&#160;10, 2006, as amended and effective as of January&#160;20, 2015, with respect to the time period prior to the adoption of <span style="white-space:nowrap">these&#160;By-Laws.</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Section</span><span style="text-decoration:underline"></span><span style="text-decoration:underline">&#160;9 of the Registrant&#8217;s Investment Advisory Agreement provides as follows</span>: </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9. Indemnity </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) The Fund hereby agrees to indemnify the Adviser and each of the Adviser&#8217;s Trustees, officers, employees, and agents (including any individual who serves at the Adviser&#8217;s request as director, officer, partner, trustee or the like of another corporation) and controlling persons (each such person being an &#8220;indemnitee&#8221;) against any liabilities and expenses, including amounts paid in satisfaction of judgments, in compromise or as fines and penalties, and counsel fees (all as provided in accordance with applicable corporate law) reasonably incurred by such indemnitee in connection with the defense or disposition of any action, suit or other proceeding, whether civil or criminal, before any court or administrative or investigative body in which he may be or may have been involved as a party or otherwise or with which he may be or may have been threatened, while acting in any capacity set forth above in this paragraph or thereafter by reason of his having acted in any such capacity, except with respect to any matter as to which he shall have been adjudicated not to have acted in good faith in the reasonable belief that his action was in the best interest of the Fund and furthermore, in the case of any criminal proceeding, so long as he had no reasonable cause to believe that the conduct was unlawful, provided, however, that (1)&#160;no indemnitee shall be indemnified hereunder against any liability to the Fund or its shareholders or any expense of such indemnitee arising by reason of (i)&#160;willful misfeasance, (ii)&#160;bad faith, (iii)&#160;gross negligence, (iv)&#160;reckless disregard of the duties involved in the conduct of his position (the conduct referred to in such clauses (i)&#160;through (v)&#160;being sometimes referred to herein as &#8220;disabling conduct&#8221;), (2)&#160;as to any matter disposed of by settlement or a compromise payment by such indemnitee, pursuant to a consent decree or otherwise, no indemnification either for said payment or for any other expenses shall be provided unless there has been a determination that such settlement or compromise is in the best interests of the Fund and that such indemnitee appears to have acted in good faith in the reasonable belief that his action was in the best interest of the Fund and did not involve disabling conduct by such indemnitee and (3)&#160;with respect to any action, suit or other proceeding voluntarily prosecuted by any indemnitee as plaintiff, indemnification shall be mandatory only if the prosecution of such action, suit or other proceeding by such indemnitee was authorized by a majority of the full Board of the Fund. Notwithstanding the foregoing the Fund shall not be obligated to provide any such indemnification to the extent such provision would waive any right which the Fund cannot lawfully waive. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) The Fund shall make advance payments in connection with the expenses of defending any action with respect to which indemnification might be sought hereunder if the Fund receives a written affirmation of the indemnitee&#8217;s good faith belief that the standard of conduct necessary for indemnification has been met and a written undertaking to reimburse the Fund unless it is subsequently determined that he is entitled to such indemnification and if the Trustees of the Fund determine that the facts then known to them would not preclude indemnification. In addition, at least one of the following conditions must be met: (A)&#160;the indemnitee shall provide a security for his undertaking, (B)&#160;the Fund shall be insured against losses arising by reason of any lawful advances, or (C)&#160;a majority of a quorum of Trustees of the Fund who are neither &#8220;interested persons&#8221; of the Fund (as defined in Section&#160;2(a)(19) of the Act) nor parties to the proceeding <span style="white-space:nowrap">(&#8220;Disinterested&#160;Non-Party&#160;Trustees&#8221;)</span> or an independent legal counsel in a written opinion, shall determine, based on a review of readily available facts (as opposed to a full trial-type inquiry), that there is reason to believe that the indemnitee ultimately will be found entitled to indemnification. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c) All determinations with respect to indemnification hereunder shall be made (1)&#160;by a final decision on the merits by a court or other body before whom the proceeding was brought that such indemnitee is not liable by reason of disabling conduct or, (2)&#160;in the absence of such a decision, by (i)&#160;a majority vote of a quorum of the Disinterested </p> </div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
 <div> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<span style="white-space:nowrap">Non-party&#160;Trustees</span> of the Fund, or (ii)&#160;if such a quorum is not obtainable or even, if obtainable, if a majority vote of such quorum so directs, independent legal counsel in a written opinion. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) The rights accruing to any indemnitee under these provisions shall not exclude any other right to which he may be lawfully entitled. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(e) Notwithstanding the foregoing, subject to any limitations provided by the 1940 Act, the Declaration and <span style="white-space:nowrap">these&#160;By-Laws,&#160;the</span> Fund shall have the power and authority to indemnify persons providing services to the Fund to the full extent provided by law as if the Fund were a corporation organized under the Delaware General Corporation Law provided that such indemnification (or contractual provision therefor) has been approved by a majority of the Trustees. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Other </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Underwriter indemnification provisions to be filed by Amendment. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additionally, the Registrant and the other funds in the Gabelli/GAMCO/Teton Fund Complex jointly maintain, at their own expense, E&amp;O/D&amp;O insurance policies for the benefit of its directors/trustees, officers and certain affiliated persons. The Registrant pays a pro rata portion of the premium on such insurance policies. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Insofar as indemnification for liability arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;31.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Business and Other Connections of Investment Adviser </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Investment Adviser, a limited liability company organized under the laws of the State of New York, acts as investment adviser to the Registrant. The Registrant is fulfilling the requirement of this Item&#160;31 to provide a list of the officers and directors of the Investment Adviser, together with information as to any other business, profession, vocation or employment of a substantial nature engaged in by the Investment Adviser or those officers and directors during the past two years, by incorporating by reference the information contained in the Form ADV of the Investment Adviser filed with the SEC pursuant to the 1940 Act (Commission <span style="white-space:nowrap">File&#160;No.&#160;801-37706).</span> </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;32.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Location of Accounts and Records </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The accounts and records of the Registrant are maintained in part at the office of the Investment Adviser at One Corporate Center, Rye, New York 10580-1422, in part at the offices of the Fund&#8217;s custodian, State Street Bank and Trust Company, at State Street Financial Center, One Lincoln Street, Boston, MA 02111, and in part at the offices of the Fund&#8217;s shareholder services and transfer agent, American Stock Transfer&#160;&amp; Trust Company, LLC, at 6201 15th Avenue, Brooklyn, NY 11219. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;33.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Management Services </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Not applicable. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:10%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;34.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Undertakings </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">1.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Not applicable. </p></td></tr></table> </div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
 <div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">2.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Not applicable. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">3.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Registrant undertakes: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(a)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">to file, during a period in which offers or sales are being made, a post-effective amendment to this Registration Statement: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">to include any prospectus required by Section&#160;10(a)(3) of the Securities Act; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(2)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">to reflect in the prospectus any facts or events after the effective date of the registration statement (or the most recent post- effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(3)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">to include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Provided, however</span>, that paragraphs a(1), a(2), and a(3) of this section do not apply to the extent the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant pursuant to Section&#160;13 or Section&#160;15(d) of the Exchange Act that are incorporated by reference into the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement. </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(b)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">that for the purpose of determining any liability under the Securities Act, each post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(c)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">to remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(d)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">that, for the purpose of determining liability under the Securities Act to any purchaser: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">if the Registrant is subject to Rule&#160;430B: </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:13%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(A)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Each prospectus filed by the Registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:13%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(B)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (x), or (xi)&#160;for the purpose of providing the information required by Section&#160;10(a) of the Securities Act shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the </p></td></tr></table> </div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
 <div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:18%">&#160;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date; or </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(2)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">if the Registrant is subject to Rule 430C: each prospectus filed pursuant to Rule 424(b) under the Securities Act as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top" align="left">(e)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">that for the purpose of determining liability of the Registrant under the Securities Act to any purchaser in the initial distribution of securities: </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; margin-left:13%; font-size:10pt; font-family:Times New Roman">The undersigned Registrant undertakes that in a primary offering of securities of the undersigned Registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned Registrant will be a seller to the purchaser and will be considered to offer or sell such securities to the purchaser: </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(1)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">any preliminary prospectus or prospectus of the undersigned Registrant relating to the offering required to be filed pursuant to Rule 424 under the Securities Act; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(2)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">free writing prospectus relating to the offering prepared by or on behalf of the undersigned Registrant or used or referred to by the undersigned Registrant; </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(3)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">the portion of any other free writing prospectus or advertisement pursuant to Rule 482 under the Securities Act relating to the offering containing material information about the undersigned Registrant or its securities provided by or on behalf of the undersigned Registrant; and </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:9%">&#160;</td>
<td style="width:4%;vertical-align:top" align="left">(4)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">any other communication that is an offer in the offering made by the undersigned Registrant to the purchaser </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">4.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Not Applicable. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">5.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the Registrant&#8217;s annual report pursuant to Section&#160;13(a) or Section&#160;15(d) of the Securities Exchange Act of 1934 that is incorporated by reference into the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">6.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue. </p></td></tr></table> </div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
 <div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">7.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Registrant undertakes to send by first class mail or other means designed to ensure equally prompt delivery, within two business days of receipt of a written or oral request, any prospectus or Statement of Additional Information. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">8.</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Registrant undertakes to only offer rights to purchase common and preferred shares together after a post-effective amendment to the Registration Statement relating to such rights has been declared effective. </p></td></tr></table> </div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
 <div> </div> <div> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933 and the Investment Company Act of 1940, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Rye, and State of New York, on the 24th day of August, 2022. </p> </div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div> <div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:40%;border:0;margin-left:auto">


<tr>

<td style="width:7%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:92%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" colspan="3">ELLSWORTH GROWTH AND INCOME FUND LTD.</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ James A. Dinsmore</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">James A. Dinsmore</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">President</p></td></tr>
</table></div> </div> <div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed below by the following persons in the capacities indicated and on the 24th day of August, 2022. </p> </div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div> <div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:96%;border:0;margin-left:auto">


<tr>

<td style="width:51%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:48%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"><span style="font-weight:bold">NAME</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">TITLE</span></td></tr>


<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ James A. Dinsmore</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">James A. Dinsmore</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">President and Trustee</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">(Principal Executive Officer)</p></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ John C. Ball</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">John C. Ball</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Treasurer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">(Principal&#160;Financial&#160;and&#160;Accounting Officer)</p></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">*</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;text-align:left">Mario J. Gabelli</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Trustee</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">*</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;text-align:left">Kinchen C. Bizzell</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Trustee</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">*</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;text-align:left">Elizabeth C. Bogan</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Trustee</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">*</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;text-align:left">James P. Conn</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Trustee</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">*</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;text-align:left">Frank&#160;J.&#160;Fahrenkopf,&#160;Jr.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Trustee</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">*</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;text-align:left">Daniel D. Harding</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Trustee</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">*</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;text-align:left">Michael J. Melarkey</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Trustee</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">*</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;text-align:left">Kuni Nakamura</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Trustee</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman;text-align:center">*</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;text-align:left">Nicolas W. Platt</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Trustee</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ James A. Dinsmore</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">James A. Dinsmore</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><span style="white-space:nowrap"><span style="white-space:nowrap">Attorney-in-Fact</span></span></td></tr>
</table></div> </div> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</p> <div>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top" align="left">*</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pursuant to Powers of Attorney </p></td></tr></table> </div> <p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>
 <div> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">EXHIBIT INDEX </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b)(ii) Amendment No.&#160;1 to Amended and Restated <span style="white-space:nowrap">By-Laws</span> of Registrant </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a)(v) <a href="d396220dex99av.htm">Statement of Preferences for Series B Cumulative Preferred Shares </a> </p> </div>
</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(A)(V)
<SEQUENCE>2
<FILENAME>d396220dex99av.htm
<DESCRIPTION>STATEMENT OF PREFERENCES FOR SERIES B CUMULATIVE PREFERRED SHARES
<TEXT>
<HTML><HEAD>
<TITLE>Statement of Preferences for Series B Cumulative Preferred Shares</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ELLSWORTH GROWTH AND INCOME FUND LTD. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>STATEMENT OF PREFERENCES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SERIES B CUMULATIVE
PREFERRED SHARES </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ellsworth Growth and Income Fund Ltd., a Delaware statutory trust (the &#147;<U>Trust</U>&#148;), hereby certifies that: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FIRST: The Board of Trustees of the Trust (the &#147;<U>Board of Trustees</U>&#148;), at a meeting duly convened and held on August&nbsp;24, 2017, pursuant to
authority expressly vested in it by Article III of the Amended and Restated Agreement and Declaration of Trust, adopted resolutions classifying an unlimited amount of shares as authorized but unissued preferred shares of the Trust. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SECOND: The Board of Trustees, at a meeting duly convened and held on May&nbsp;23, 2022, approved the designation, issuance and sale by the Trust of up to
$30,000,000 in liquidation preference of Series B Cumulative Preferred Shares, par value $0.01 per share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THIRD: The pricing committee of the Board of
Trustees (the &#147;<U>Pricing Committee</U>&#148;), at a meeting duly convened and held on June&nbsp;29, 2022, approved the issuance and sale by the Trust of up to 3,000,000 shares of Series B Cumulative Preferred Shares, par value $0.01 per share.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOURTH: The preferences, rights, voting powers, restrictions, limitations as to dividends and distributions, qualifications, and terms and conditions of
redemption of the Trust&#146;s<B> </B>Series B Cumulative Preferred Shares, par value $0.01&nbsp;per share, as set by the Board of Trustees and the Pricing Committee, are as follows: </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DESIGNATION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Series B Cumulative
Preferred Shares: A series of 3,000,000 preferred shares, par value $0.01&nbsp;per share, liquidation preference $10.00&nbsp;per share, is hereby designated &#147;Series B Cumulative Preferred Shares&#148; (the &#147;<U>Series B Preferred
Shares</U>&#148;). Each Series B Preferred Share may be issued on a date to be determined by the Board of Trustees or its delegatees and as are set forth in this Statement of Preferences; and shall have such other preferences, rights, voting powers,
restrictions, limitations as to dividends and distributions, qualifications and terms and conditions of redemption, in addition to those required by applicable law or set forth in the Governing Documents applicable to preferred shares of the Trust
(&#147;<U>Preferred Shares</U>&#148;), as are set forth in this Statement of Preferences. The Series B Preferred Shares shall constitute a separate series of Preferred Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FIFTH: This Statement of Preferences sets forth the rights, powers, preferences and privileges of the holders of the Series B Preferred Shares and the
provisions set forth herein shall operate either as additions to or modifications of the rights, powers, preferences and privileges of the holders of the Series B Preferred Shares under the Declaration (as defined herein), as the context may
require. To the extent the provisions set forth herein conflict with the provisions of the Declaration with respect to any such rights, powers, preferences and privileges, this Statement of Preferences shall control. Except as contemplated by the
immediately preceding sentence, the Declaration shall control as to the Trust generally and the rights, powers, preferences and privileges of the other shareholders of the Trust. </P>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PART I </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DEFINITIONS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless the context or use
indicates another or different meaning or intent, each of the following terms when used in this Statement of Preferences shall have the meaning ascribed to it below, whether such term is used in the singular or plural and regardless of tense: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<U>1940 Act</U>&#148; means the Investment Company Act of 1940, as amended, or any successor statute. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<U>Adviser</U>&#148; means Gabelli Funds, LLC, a New York limited liability company, or such other Person as shall be serving as the investment adviser
of the Trust. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<U>Asset Coverage</U>&#148; means asset coverage, as determined in accordance with Section&nbsp;18(h) of the 1940 Act, of at least
200% with respect to all outstanding senior securities of the Trust which are stock, including all Outstanding Series B Preferred Shares (or such other asset coverage as may in the future be specified in or under the 1940 Act as the minimum asset
coverage for senior securities which are stock of a <FONT STYLE="white-space:nowrap">closed-end</FONT> investment company as a condition of declaring dividends on its common stock), determined on the basis of values calculated as of a time within
48&nbsp;hours (not including Saturdays, Sundays or holidays) next preceding the time of such determination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<U>Board of Trustees</U>&#148; means
the Board of Trustees of the Trust or any duly authorized committee thereof as permitted by applicable law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<U>Business Day</U>&#148; means a day
on which the New York Stock Exchange is open for trading and that is neither a Saturday nor a Sunday. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<U><FONT STYLE="white-space:nowrap">By-Laws</FONT></U>&#148; means the Amended and Restated <FONT STYLE="white-space:nowrap">By-Laws</FONT> of the
Trust, as amended from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<U>Common Shares</U>&#148; means the common shares of beneficial interest, par value $0.01&nbsp;per share, of
the Trust. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<U>Date of Original Issue</U>&#148; means July&nbsp;1, 2022 with respect to the Series B Preferred Shares, and for the purposes of this
Statement of Preferences shall have a correlative meaning with respect to any other class or series of Preferred Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<U>Declaration</U>&#148;
means the Amended and Restated Agreement and Declaration of Trust of the Trust, dated as of January&nbsp;16, 2006, as amended on January&nbsp;20, 2015 and September&nbsp;9, 2015, and as further amended, supplemented or restated from time to time
(including by this Statement of Preferences or by way of any other supplement or Statement of Preferences authorizing or creating a class of shares of beneficial interest in the Trust). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<U>Deposit Assets</U>&#148; means cash, Short-Term Money Market Instruments and U.S.&nbsp;Government Obligations. Each Deposit Asset shall be deemed to
have a value equal to its principal or face amount payable at maturity plus any interest payable thereon after delivery of such Deposit Asset but only if payable on or prior to the applicable payment date in advance of which the relevant deposit is
made. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<U>Dividend-Disbursing Agent</U>&#148; means, with respect to the Series B Preferred Shares, American Stock Transfer&nbsp;&amp; Trust
Company. and its successors or any other dividend-disbursing agent appointed by the Trust and, with respect to any other class or series of Preferred Shares, the Person appointed by the Trust as dividend-disbursing or paying agent with respect to
such class or series. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<U>Dividend Payment Date</U>&#148; means with respect to the Series B Preferred Shares, any date on which
dividends and distributions declared by, or under authority granted by, the Board of Trustees thereon are payable pursuant to the provisions of paragraph&nbsp;2(a) of Part&nbsp;II of this Statement of Preferences and shall for the purposes of this
Statement of Preferences have a correlative meaning with respect to any other class or series of Preferred Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<U>Dividend Period</U>&#148;
shall have the meaning set forth in paragraph&nbsp;2(a) of Part II hereof, and for the purposes of this Statement of Preferences shall have a correlative meaning with respect to any other class or series of Preferred Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<U>Governing Documents</U>&#148; means the Declaration and the <FONT STYLE="white-space:nowrap">By-Laws.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<U>Liquidation Preference</U>&#148; shall, with respect to the Series B Preferred Shares, have the meaning set forth in paragraph&nbsp;3(a) of
Part&nbsp;II hereof, and for the purposes of this Statement of Preferences shall have a correlative meaning with respect to any other class or series of Preferred Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<U>Notice of Redemption</U>&#148; shall have the meaning set forth in paragraph&nbsp;4(d)(i) of Part II hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<U>Outside Redemption Date</U>&#148; means the 30th Business Day after a Series B Asset Coverage Cure Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<U>Outstanding</U>&#148; means, as of any date, Preferred Shares theretofore issued by the Trust except: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a)&nbsp;any such Preferred Shares theretofore redeemed, repurchased, cancelled or otherwise reacquired by the Trust or delivered to the Trust for redemption,
repurchase, cancellation or other acquisition by the Trust; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b)&nbsp;any such Preferred Share as to which a Notice of Redemption shall have been given
and for whose payment at the redemption thereof Deposit Assets in the necessary amount are held by the Trust in trust for, or have been irrevocably deposited with the relevant disbursing agent for payment to, the holder of such share pursuant to
this Statement of Preferences with respect thereto; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c)&nbsp;any such Preferred Share in exchange for or in lieu of which other shares have been
issued and delivered. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, for purposes of voting rights (including the determination of the number of shares required to
constitute a quorum), any Preferred Shares as to which the Trust or any subsidiary of the Trust is the holder will be disregarded and deemed not Outstanding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<U>Person</U>&#148; means and includes an individual, a partnership, the Trust, a trust, a corporation, a limited liability company, an unincorporated
association, a joint venture or other entity or a government or any agency or political subdivision thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<U>Preferred Shares</U>&#148; means
all series of the preferred shares, par value $0.01&nbsp;per share, of the Trust, and includes the Series B Preferred Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<U>Record
Date</U>&#148; shall have the meaning set forth in paragraph 2(a) of Part II hereof, and for the purposes of this Statement of Preferences shall have a correlative meaning with respect to any other class or series of Preferred Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<U>Redemption</U><U></U><U>&nbsp;Price</U>&#148; has the meaning set forth in paragraph&nbsp;4(a) of Part II hereof, and for the purposes of this
Statement of Preferences shall have a correlative meaning with respect to any other class or series of Preferred Shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<U>Series B Preferred Shares</U>&#148; means the Series B Cumulative Preferred Shares, par value
$0.01&nbsp;per share, of the Trust. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<U>Series B Asset Coverage Cure Date</U>&#148; means, with respect to the failure by the Trust to maintain
Asset Coverage (as required by paragraph&nbsp;6(a)(i) of Part II hereof) as of the last Business Day of each March, June, September and December of each year, 49&nbsp;days following such Business Day. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<U>Short-Term Money Market Instruments</U>&#148; means the following types of instruments if, on the date of purchase or other acquisition thereof by
the Trust, the remaining term to maturity thereof is not in excess of 180 days: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">commercial paper rated <FONT STYLE="white-space:nowrap">A-1</FONT> if such commercial paper matures in 30 days
or <FONT STYLE="white-space:nowrap">A-1+</FONT> if such commercial paper matures in over 30 days; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">demand or time deposits in, and banker&#146;s acceptances and certificates of deposit of (A)&nbsp;a depository
institution or trust company incorporated under the laws of the United States of America or any state thereof or the District of Columbia or (B)&nbsp;a United States branch office or agency of a foreign depository institution (provided that such
branch office or agency is subject to banking regulation under the laws of the United States, any state thereof or the District of Columbia); </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">overnight funds; and </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">U.S. Government Obligations. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<U>Trust</U>&#148; means Ellsworth Growth and Income Fund Ltd., a Delaware statutory trust. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<U>U.S. Government Obligations</U>&#148; means direct obligations of the United States or obligations issued by its agencies or instrumentalities that
are entitled to the full faith and credit of the United States and that, other than United States Treasury Bills, provide for the periodic payment of interest and the full payment of principal at maturity or call for redemption. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;<U>Voting Period</U>&#148; shall have the meaning set forth in paragraph&nbsp;5(b) of Part II hereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PART II </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SERIES B CUMULATIVE PREFERRED SHARES </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.
Number of Shares; Ranking. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) The initial number of authorized Shares constituting the Series B Preferred Shares to be issued is 3,000,000. No
fractional Series B Preferred Shares shall be issued. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) Series B Preferred Shares which at any time have been redeemed or purchased by the Trust shall,
after such redemption or purchase, have the status of authorized but unissued Preferred Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c) The Series B Preferred Shares shall rank on a parity
with any other series of Preferred Shares as to the payment of dividends, distributions and liquidation preference to which such Shares are entitled. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d)
No holder of Series B Preferred Shares shall have, solely by reason of being such a holder, any preemptive or other right to acquire, purchase or subscribe for any Preferred Shares or Common Shares or other securities of the Trust which it may
hereafter issue or sell. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. Dividends and Distributions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) Holders of Series B Preferred Shares shall be entitled to receive, when, as and if authorized by, or under authority granted by, the Board and declared by
the Fund, out of funds legally available therefor, cumulative cash dividends and distributions at the rate of 4.00% per annum (computed on the basis of a 360 day year consisting of twelve 30 day months) of the Liquidation Preference on the Series B
Preferred Shares and no more. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dividends and distributions will be payable semiannually on June&nbsp;26 and December&nbsp;26 in each year (each a
&#147;Dividend Payment Date&#148;) commencing on December&nbsp;26, 2022 (or, if any such day is not a Business Day, then on the next succeeding Business Day) to holders of record of Series B Preferred Shares as they appear on the share register of
the Fund at the close of business on the fifth Business Day preceding the Dividend Payment Date (each, a &#147;Record Date&#148;) in preference to dividends and distributions on Common Shares and any other capital shares of the Trust ranking junior
to the Series B Preferred Shares in payment of dividends and distributions. Dividends and distributions on Series B Preferred Shares that were originally issued on the Date of Original Issue shall accumulate from the Date of Original Issue.
Dividends and distributions on all other Series B Preferred Shares shall accumulate from (i)&nbsp;the date on which such shares are originally issued if such date is a Dividend Payment Date, (ii)&nbsp;the immediately preceding Dividend Payment Date
if the date on which such shares are originally issued is other than a Dividend Payment Date and is on or before a Record Date or (iii)&nbsp;the immediately following Dividend Payment Date if the date on which such shares are originally issued is
during the period between a Record Date and a Dividend Payment Date. Each period beginning on and including a Dividend Payment Date (or the Date of Original Issue, in the case of the first dividend period after the issuance of such shares) and
ending on but excluding the next succeeding Dividend Payment Date is referred to herein as a &#147;Dividend Period.&#148; Dividends and distributions on account of arrears for any past Dividend Period or in connection with the redemption of Series B
Preferred Shares may be declared and paid at any time, without reference to any Dividend Payment Date, to holders of record on such date not exceeding 30 days preceding the payment date thereof as shall be fixed by the Board of Trustees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b)&nbsp;(i) No full dividends or distributions shall be declared or paid on Series B Preferred Shares for any Dividend Period or part thereof unless full
cumulative dividends and distributions due through the most recent Dividend Payment Dates therefor for all series of Preferred Shares ranking on a parity with the Series B </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Preferred Shares as to the payment of dividends and distributions have been or contemporaneously are declared and paid through the most recent Dividend Payment Dates therefor. If full cumulative
dividends and distributions due have not been paid on all such Outstanding Preferred Shares, any dividends and distributions being paid on such Preferred Shares (including the Series B Preferred Shares) will be paid as nearly pro rata as possible in
proportion to the respective amounts of dividends and distributions accumulated but unpaid on each such series of Preferred Shares on the relevant Dividend Payment Date. No holders of Series B Preferred Shares shall be entitled to any dividends or
distributions, whether payable in cash, property or shares, in excess of full cumulative dividends and distributions as provided in this paragraph 2(b)(i) on Series B Preferred Shares. No interest or sum of money in lieu of interest shall be payable
in respect of any dividend payments on any Series B Preferred Shares that may be in arrears. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;For so long as Series B Preferred Shares are
Outstanding, the Trust shall not pay any dividend or other distribution (other than a dividend or distribution paid in Common Shares, or options, warrants or rights to subscribe for or purchase Common Shares or other shares, if any, ranking junior
to the Series B Preferred Shares as to payment of dividends and the distribution of assets upon liquidation) in respect of the Common Shares or any other shares of the Trust ranking junior to the Series B Preferred Shares as to the payment of
dividends and the distribution of assets upon liquidation, or call for redemption, redeem, purchase or otherwise acquire for consideration any Common Shares or any other shares of the Trust ranking junior to the Series B Preferred Shares as to the
payment of dividends and the distribution of assets upon liquidation (except by conversion into or exchange for shares of the Trust ranking junior to the Series B Preferred Shares as to payment of dividends and the distribution of assets upon
liquidation), unless, in each case, (A)&nbsp;immediately thereafter, the Trust shall have Asset Coverage, (B)&nbsp;all cumulative dividends and distributions on all Series B Preferred Shares due on or prior to the date of the transaction have been
declared and paid (or shall have been declared and sufficient funds for the payment thereof deposited with the applicable Dividend-Disbursing Agent) and (C)&nbsp;the Trust has redeemed the full number of Series B Preferred Shares to be redeemed
mandatorily pursuant to any provision contained herein for mandatory redemption. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;Any dividend payment made on the Series B Preferred Shares
shall first be credited against the dividends and distributions accumulated with respect to the earliest Dividend Period for which dividends and distributions have not been paid. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c) Not later than the Business Day immediately preceding each Dividend Payment Date, the Trust shall deposit with the Dividend-Disbursing Agent Deposit
Assets having an initial combined value sufficient to pay the dividends and distributions that are payable on such Dividend Payment Date, which Deposit Assets shall mature (if such assets constitute debt securities or time deposits) on or prior to
such Dividend Payment Date. The Trust may direct the Dividend-Disbursing Agent with respect to the investment of any such Deposit Assets, provided that such investment consists exclusively of Deposit Assets and provided further that the proceeds of
any such investment will be available at the opening of business on such Dividend Payment Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. Liquidation Rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) In the event of any liquidation, dissolution or winding up of the affairs of the Trust, whether voluntary or involuntary, the holders of Series B
Preferred Shares shall be entitled to receive out of the assets of the Trust available for distribution to shareholders, after satisfying claims of creditors but before any distribution or payment shall be made in respect of the Common Shares or any
other shares of the Trust ranking junior to the Series B Preferred Shares as to liquidation payments, a liquidation distribution in the amount of $10.00&nbsp;per share (the &#147;<U>Liquidation Preference</U>&#148;), plus an amount equal to all
unpaid dividends and distributions accumulated to and including the date fixed for such distribution or payment (whether or not earned or declared by the Trust, but excluding interest thereon), and such holders shall be entitled to no further
participation in any distribution or payment in connection with any such liquidation, dissolution or winding up of the Trust. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) If, upon any liquidation, dissolution or winding up of the affairs of the Trust, whether voluntary or
involuntary, the assets of the Trust available for distribution among the holders of all Outstanding Series B Preferred Shares, and any other Outstanding class or series of Preferred Shares ranking on a parity with the Series B Preferred Shares as
to payment upon liquidation, shall be insufficient to permit the payment in full to such holders of Series B Preferred Shares of the Liquidation Preference plus accumulated and unpaid dividends and distributions and the amounts due upon liquidation
with respect to such other Preferred Shares, then such available assets shall be distributed among the holders of Series B Preferred Shares and such other Preferred Shares ratably in proportion to the respective preferential liquidation amounts to
which they are entitled. Notwithstanding any other provision of this Statement of Preferences, Series B Preferred Shares submitted for redemption pursuant to paragraph 4(c) hereof will remain subject to the foregoing liquidation terms until the
applicable redemption date. Unless and until the Liquidation Preference plus accumulated and unpaid dividends and distributions has been paid in full to the holders of Series B Preferred Shares, no dividends or distributions will be made to holders
of the Common Shares or any other shares of the Trust ranking junior to the Series B Preferred Shares as to liquidation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. Redemption. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Series B Preferred Shares shall be redeemed by the Trust as provided below: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) Mandatory Redemptions. If the Trust is required to redeem any Preferred Shares (which may include Series B Preferred Shares) pursuant to
paragraph&nbsp;6(b) of Part II hereof, then the Trust shall, to the extent permitted by the 1940 Act and Delaware law, by the close of business on such Series B Asset Coverage Cure Date, fix a redemption date that is on or before the Outside
Redemption Date and proceed to redeem shares as set forth in paragraph&nbsp;4(d) hereof; provided, however, that the Trust may fix a redemption date that is after the Outside Redemption Date if the Board of Trustees determines in good faith that
extraordinary market conditions exist as a result of which disposal by the Trust of securities owned by it is not reasonably practicable, or is not reasonably practicable at fair value. On such redemption date, the Trust shall redeem, out of funds
legally available therefor, (i)&nbsp;the number of Preferred Shares, which, to the extent permitted by the 1940 Act and Delaware law, at the option of the Trust may include any proportion of Series B Preferred Shares or any other series of Preferred
Shares, equal to the minimum number of shares the redemption of which, if such redemption had occurred immediately prior to the opening of business on such Series B Asset Coverage Cure Date, would have resulted in the Trust having Asset Coverage
immediately prior to the opening of business on such Series B Asset Coverage Cure Date or (ii)&nbsp;if such Asset Coverage cannot be so restored, all of the Outstanding Series B Preferred Shares, at a price equal to the Liquidation Preference plus
accumulated but unpaid dividends and distributions (whether or not earned or declared by the Trust) to, but not including, the date of redemption (the &#147;<U>Redemption Price</U>&#148;). In the event that Preferred Shares are redeemed pursuant to
paragraph&nbsp;6(b) of Part II hereof, the Trust may, but is not required to, redeem an additional number of Series B Preferred Shares pursuant to this paragraph&nbsp;4(a) which, when aggregated with other Preferred Shares redeemed by the Trust,
permits the Trust to have with respect to the Preferred Shares (including the Series B Preferred Shares) remaining Outstanding after such redemption Asset Coverage of as much as 220%. In the event that all of the Series B Preferred Shares then
Outstanding are required to be redeemed pursuant to paragraph&nbsp;6 of Part II hereof, the Trust shall redeem such shares at the Redemption&nbsp;Price and proceed to do so as set forth in paragraph&nbsp;4(d) hereof. (b)&nbsp;Optional Redemptions
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) Optional Redemption. Prior to June&nbsp;26, 2024, the Series B Preferred Shares are not subject to optional redemption by the Trust unless the
redemption is necessary, in the judgment of the Board of Trustees, to maintain the Trust&#146;s status as a regulated investment company under Subchapter M of the Internal Revenue </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Code of 1986, as amended. Commencing June&nbsp;26, 2024, and thereafter, and prior thereto to the extent necessary to maintain the Trust&#146;s status as a regulated investment company under
Subchapter M of the Internal Revenue Code of 1986, as amended, to the extent permitted by the 1940 Act and Delaware law, the Trust may at any time upon Notice of Redemption redeem the Series B Preferred Shares in whole or in part at the Redemption
Price. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c) Holder Put Options. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Trust will redeem all
or any part of the Series B Preferred Shares that holders have properly submitted for redemption and not withdrawn during the <FONT STYLE="white-space:nowrap">60-day</FONT> period prior to each of June&nbsp;26, 2023 and June&nbsp;26, 2024 at the
Redemption Price. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d)&nbsp;Procedures for Redemption. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(i)&nbsp;If the Trust shall determine or be required to redeem Series B Preferred Shares pursuant to paragraph&nbsp;4(a) or paragraph 4(b) of this Part II, it
shall mail a written notice of redemption (&#147;<U>Notice of Redemption</U>&#148;) with respect to such redemption by first class mail, postage prepaid, to each holder of the shares to be redeemed at such holder&#146;s address as the same appears
on the share register of the Trust on the close of business on such date as the Board of Trustees or its delegatee may determine, which date shall not be earlier than the second Business Day prior to the date upon which such Notice of Redemption is
mailed to the holders of Series B Preferred Shares. Each such Notice of Redemption shall state: (A)&nbsp;the redemption date as established by the Board of Trustees or its delegatee; (B)&nbsp;the number or percentage of Series B Preferred Shares to
be redeemed; (C)&nbsp;the CUSIP number(s) of such shares; (D)&nbsp;the Redemption&nbsp;Price (specifying the amount of accumulated dividends and distributions to be included therein); (E)&nbsp;the place or places where the certificate(s) for such
shares (properly endorsed or assigned for transfer, if the Board of Trustees or its delegatee shall so require and the Notice of Redemption shall so state), if any, are to be surrendered for payment in respect of such redemption; (F)&nbsp;that
dividends and distributions on the shares to be redeemed will cease to accrue on such redemption date; (G)&nbsp;the provisions of this paragraph&nbsp;4 under which such redemption is made; and (H)&nbsp;in the case of a redemption pursuant to
paragraph&nbsp;4(b), any conditions precedent to such redemption. If fewer than all Series B Preferred Shares held by any holder are to be redeemed, the Notice of Redemption mailed to such holder also shall specify the number or percentage of shares
to be redeemed from such holder. No defect in the Notice of Redemption or the mailing thereof shall affect the validity of the redemption proceedings, except as required by applicable law. The Notice of Redemption shall be mailed to the holders of
Series B Preferred Shares to be redeemed not fewer than 15 days nor more than 40 days prior to the date fixed for redemption; provided, however, that shorter notice may be given in the case of a redemption pursuant to paragraph 4(a). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;If the Trust shall give a Notice of Redemption, then by the close of business on the Business Day preceding the redemption date specified in the
Notice of Redemption (so long as any conditions precedent to such redemption have been met) or, if the Dividend-Disbursing Agent so agrees, another date not later than the redemption date, the Trust shall (A)&nbsp;deposit with the
Dividend-Disbursing Agent Deposit Assets that shall mature (if such assets constitute debt securities or time deposits) on or prior to such redemption date having an initial combined value sufficient to effect the redemption of the Series B
Preferred Shares to be redeemed and (B)&nbsp;give the Dividend-Disbursing Agent irrevocable instructions and authority to pay the Redemption&nbsp;Price to the holders of the Series B Preferred Shares called for redemption on the redemption date. The
Trust may direct the Dividend-Disbursing Agent with respect to the investment of any Deposit Assets so deposited provided that the proceeds of any such investment will be available at the opening of business on such redemption date. Upon the date of
such deposit (unless the Trust shall default in making payment of the Redemption&nbsp;Price), all rights of the holders of the Series B Preferred Shares so called for redemption shall cease and terminate except the right of the holders thereof to
receive the Redemption&nbsp;Price thereof and such shares shall no longer be deemed Outstanding for any purpose. The </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Trust shall be entitled to receive, promptly after the date fixed for redemption, any cash in excess of the aggregate Redemption Price of the Series B Preferred Shares called for redemption on
such date and any remaining Deposit Assets. Any assets so deposited that are unclaimed at the end of two years from such redemption date shall, to the extent permitted by law, be repaid to the Trust, after which the holders of the Series B Preferred
Shares so called for redemption shall look only to the Trust for payment of the Redemption&nbsp;Price thereof. The Trust shall be entitled to receive, from time to time after the date fixed for redemption, any interest on the Deposit Assets so
deposited. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;On or after the redemption date, each holder of Series B Preferred Shares that are subject to redemption shall surrender such
shares to the Trust as instructed in the Notice of Redemption and shall then be entitled to receive the cash Redemption&nbsp;Price, without interest. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(iv)&nbsp;In the case of any redemption of less than all of the Series B Preferred Shares pursuant to this Statement of Preferences, such redemption shall be
made pro rata from each holder of Series B Preferred Shares in accordance with the respective number of shares held by each such holder on the record date for such redemption. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(v)&nbsp;Notwithstanding the other provisions of this paragraph&nbsp;4, the Trust shall not redeem any Series B Preferred Shares unless all accumulated and
unpaid dividends and distributions on all Outstanding Series B Preferred Shares and other Preferred Shares ranking on a parity with the Series B Preferred Shares with respect to dividends and distributions for all applicable past Dividend Periods
(whether or not earned or declared by the Trust) shall have been or are contemporaneously paid or declared and Deposit Assets for the payment of such dividends and distributions shall have been deposited with the Dividend-Disbursing Agent as set
forth in paragraph&nbsp;2(c) of Part II hereof, provided, however, that the foregoing shall not prevent the purchase or acquisition of Outstanding Preferred Shares pursuant to the successful completion of an otherwise lawful purchase or exchange
offer made on the same terms to holders of all Outstanding Series B Preferred Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the Trust shall not have funds legally available for the
redemption of, or is otherwise unable to redeem, all the Series B Preferred Shares or other Preferred Shares designated to be redeemed on any redemption date, the Trust shall redeem on such redemption date the number of Series B Preferred Shares and
other Preferred Shares so designated as it shall have legally available funds, or is otherwise able, to redeem ratably on the basis of the Redemption&nbsp;Price from each holder whose shares are to be redeemed, and the remainder of the Series B
Preferred Shares and other Preferred Shares designated to be redeemed shall be redeemed on the earliest practicable date on which the Trust shall have funds legally available for the redemption of, or is otherwise able to redeem, such shares upon
Notice of Redemption. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5.&nbsp;Voting Rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a)&nbsp;General. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Except as otherwise provided in the
Governing Documents or a resolution of the Board of Trustees, or as required by applicable law, holders of Series B Preferred Shares shall have no power to vote on any matter except matters submitted to a vote of the Common Shares. In any matter
submitted to a vote of the holders of the Common Shares, each holder of Series B Preferred Shares shall be entitled to one vote for each Series B Preferred Share held and the holders of the Outstanding Preferred Shares, including Series B Preferred
Shares, and the Common Shares shall vote together as a single class; provided, however, that the holders of the Outstanding Preferred Shares, including Series B Preferred Shares, shall be entitled, as a separate class, to the exclusion of the
holders of all other securities and classes of capital shares of the Trust, to elect two of the Trust&#146;s trustees. Subject to paragraph&nbsp;5(b) of Part II hereof, the holders of the outstanding capital shares of the Trust, including the
holders of the Outstanding Preferred Shares, including the Series B Preferred Shares, voting as a single class, shall elect the balance of the trustees. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b)&nbsp;Right to Elect Majority of Board of Trustees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During any period in which any one or more of the conditions described below shall exist (such period being referred to herein as a &#147;<U>Voting
Period</U>&#148;), the number of trustees constituting the Board of Trustees shall be automatically increased by the smallest number that, when added to the two trustees elected exclusively by the holders of Preferred Shares pursuant to paragraph
5(a) above, would constitute a majority of the Board of Trustees as so increased by such smallest number; and the holders of Preferred Shares shall be entitled, voting separately as one class (to the exclusion of the holders of all other securities
and classes of shares of the Trust), to elect such smallest number of additional trustees, together with the two trustees that such holders are in any event entitled to elect pursuant to paragraph 5(a) above. The Trust and the Board of Trustees
shall take all necessary action, including amending the <FONT STYLE="white-space:nowrap">By-Laws,</FONT> to effect an increase in the number of trustees as described in the preceding sentence. A Voting Period shall commence: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(i)&nbsp;if at any time accumulated dividends and distributions (whether or not earned or declared, and whether or not funds are then legally available in an
amount sufficient therefor) on the Outstanding Series B Preferred Shares equal to at least two full years&#146; dividends and distributions shall be due and unpaid and sufficient Deposit Assets shall not have been deposited with the
Dividend-Disbursing Agent for the payment of such accumulated dividends and distributions;&nbsp;or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;if at any time holders of any other
Preferred Shares are entitled to elect a majority of the trustees of the Trust under the 1940 Act or Statement of Preferences creating such shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon
the termination of a Voting Period, the voting rights described in this paragraph&nbsp;5(b) shall cease, subject always, however, to the reverting of such voting rights in the holders of Preferred Shares upon the further occurrence of any of the
events described in this paragraph&nbsp;5(b). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c)&nbsp;Voting Procedures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(i)&nbsp;As soon as practicable after the accrual of any right of the holders of Preferred Shares to elect additional trustees as described in
paragraph&nbsp;5(b) above, the Trust shall call a special meeting of such holders and shall mail a notice of such special meeting to such holders, such meeting to be held not less than 10 nor more than 20&nbsp;days after the date of mailing of such
notice. If the Trust fails to send such notice or if the Trust does not call such a special meeting, it may be called by any such holder on like notice. The record date for determining the holders entitled to notice of and to vote at such special
meeting shall be the close of business on the day on which such notice is mailed or such other date as the Board of Trustees shall determine. At any such special meeting and at each meeting held during a Voting Period, such holders of Preferred
Shares, voting together as a class (to the exclusion of the holders of all other securities and classes of capital shares of the Trust), shall be entitled to elect the number of trustees prescribed in paragraph&nbsp;5(b) above on a <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">one-vote-per-share</FONT></FONT></FONT> basis. At any such meeting, or adjournment thereof in the absence of a quorum, a majority of such holders present in
person or by proxy shall have the power to adjourn the meeting without notice, other than by an announcement at the meeting, to a date not more than 120&nbsp;days after the original record date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;For purposes of determining any rights of the holders of Series B Preferred Shares to vote on any matter or the number of shares required to
constitute a quorum, whether such right is created by this Statement of Preferences, by the other provisions of the Governing Documents, by statute or otherwise, any Series B Preferred Share which is not Outstanding shall not be counted. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;The terms of office of all persons who are trustees of the Trust at the time of a special meeting of
holders of Preferred Shares, including Series B Preferred Shares, to elect trustees, shall continue following such meeting, notwithstanding the election at such meeting by such holders of the number of trustees that they are entitled to elect, and
the persons so elected by such holders, together with the two incumbent trustees elected by the holders of Preferred Shares, including Series B Preferred Shares, and the remaining incumbent trustees elected by the holders of the Common Shares and
Preferred Shares, shall constitute the duly elected trustees of the Trust. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(iv)&nbsp;Upon the expiration of a Voting Period, the terms of office of the
additional trustees elected by the holders of Preferred Shares pursuant to paragraph&nbsp;5(b) above shall expire at the earliest time permitted by law and the remaining trustees shall constitute the trustees of the Trust and the voting rights of
such holders of Preferred Shares, including Series B Preferred Shares, to elect additional trustees pursuant to paragraph&nbsp;5(b) above shall cease, subject to the provisions of the last sentence of paragraph&nbsp;5(b). Upon the expiration of the
terms of the trustees elected by the holders of Preferred Shares pursuant to paragraph&nbsp;5(b) above, the number of trustees shall be automatically reduced to the number and composition of trustees on the Board immediately preceding such Voting
Period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(e)&nbsp;Exclusive Remedy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless otherwise
required by law, the holders of Series B Preferred Shares shall not have any rights or preferences other than those specifically set forth herein. The holders of Series B Preferred Shares shall have no preemptive rights or rights to cumulative
voting. In the event that the Trust fails to pay any dividends and distributions on the Series B Preferred Shares, or fails to complete any voluntary or mandatory redemption, the exclusive remedy of the holders shall be the right to vote for
trustees pursuant to the provisions of this paragraph&nbsp;5. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6.&nbsp;Coverage Tests. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a)&nbsp;Determination of Compliance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For so long as any
Series B Preferred Shares are Outstanding, the Trust shall make the following determinations: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(i)&nbsp;Asset Coverage. The Trust shall have Asset
Coverage as of the last Business Day of each March, June, September and December of each year in which any Series B Preferred Shares are Outstanding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b)&nbsp;Failure to Meet Asset Coverage. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If the Trust fails to
have Asset Coverage as provided in paragraph&nbsp;6(a)(i) hereof and such failure is not cured as of the Series B Asset Coverage Cure Date, (i)&nbsp;the Trust shall give a Notice of Redemption as described in paragraph&nbsp;4 of Part II hereof with
respect to the redemption of a sufficient number of Preferred Shares, which at the Trust&#146;s determination (to the extent permitted by the 1940 Act and Delaware law) may include any proportion of Series B Preferred Shares, to enable it to meet
the requirements of paragraph&nbsp;6(a)(i) above, and, at the Trust&#146;s discretion, such additional number of Series B Preferred Shares or other Preferred Shares in order that the Trust have Asset Coverage with respect to the Series B Preferred
Shares and any other Preferred Shares remaining Outstanding after such redemption as great as 220%, and (ii)&nbsp;deposit with the Dividend-Disbursing Agent Deposit Assets having an initial combined value sufficient to effect the redemption of the
Series B Preferred Shares or other Preferred Shares to be redeemed, as contemplated by paragraph&nbsp;4 of Part II hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c)&nbsp;Status of
Shares&nbsp;Called for Redemption. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of determining whether the requirements of paragraph&nbsp;6(a)(i) hereof are satisfied, (i)&nbsp;no
Series B Preferred Share shall be deemed to be Outstanding for purposes of any computation if, prior to or concurrently with such determination, sufficient Deposit Assets to pay the full Redemption&nbsp;Price for such share shall have been deposited
in trust with the Dividend-Disbursing Agent (or applicable paying agent) and the requisite Notice of Redemption shall have been given, and (ii)&nbsp;such Deposit Assets deposited with the <FONT STYLE="white-space:nowrap">Dividend-Disbursing</FONT>
Agent (or paying agent) shall not be included. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7.&nbsp;Limitation on Incurrence of Additional Indebtedness and Issuance of Additional Preferred Shares.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a)&nbsp;So long as any Series B Preferred Shares are Outstanding and the Trust is permitted to issue indebtedness under its fundamental investment
restrictions, the Trust may issue and sell one or more series of a class of senior securities of the Trust representing indebtedness under Section&nbsp;18 of the 1940 Act and/or otherwise create or incur indebtedness, provided that, immediately
after giving effect to the incurrence of such indebtedness and to its receipt and application of the proceeds thereof, the Trust shall have an &#147;asset coverage&#148; for all senior securities representing indebtedness, as defined in
Section&nbsp;18(h) of the 1940 Act, of at least 300% of the amount of all indebtedness of the Trust then Outstanding and no such additional indebtedness shall have any preference or priority over any other indebtedness of the Trust upon the
distribution of the assets of the Trust or in respect of the payment of interest. Any possible liability resulting from lending and/or borrowing portfolio securities, entering into reverse repurchase agreements, entering into futures contracts and
writing options or the use of any other financial instrument that may have the effect of creating leverage but is not considered a senior security representing indebtedness under the 1940 Act, to the extent such transactions are made in accordance
with the investment restrictions of the Trust then in effect, shall not be considered to be indebtedness limited by this paragraph 7(a). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b)&nbsp;So long
as any Series B Preferred Shares are Outstanding, the Trust may issue and sell shares of one or more other series of Preferred Shares constituting a series of a class of senior securities of the Trust representing stock under Section&nbsp;18 of the
1940 Act in addition to the Series B Preferred Shares and other Preferred Shares then Outstanding, provided that (i)&nbsp;the Trust shall, immediately after giving effect to the issuance of such additional Preferred Shares and to its receipt and
application of the proceeds thereof, including, without limitation, to the redemption of Preferred Shares for which a Notice of Redemption&nbsp;has been mailed prior to such issuance, have an &#147;asset coverage&#148; for all senior securities
which are stock, as defined in Section&nbsp;18(h) of the 1940 Act, of at least 200% of the sum of the Liquidation Preference of the Series B Preferred Shares and all other Preferred Shares then Outstanding, and (ii)&nbsp;no such additional Preferred
Shares shall have any preference or priority over any other Preferred Shares upon liquidation or the distribution of the assets of the Trust or in respect of the payment of dividends. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8. Treatment of Series B Preferred Shares for Tax Purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Unless otherwise required by law, the holders of the Series B Preferred Shares shall treat Series B Preferred Shares as equity of the Trust for all U.S.
federal, local and other income tax purposes. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PART&nbsp;III </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ABILITY OF THE BOARD OF TRUSTEES TO MODIFY </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE STATEMENT OF PREFERENCES </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.
Modification. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) So long as any Series B Preferred Shares are Outstanding, the Trust shall not amend, alter or repeal the provisions of this Statement
of Preferences so as to in the aggregate materially and adversely affect the rights and preferences set forth in any Statement of Preferences, including those of the Series B Preferred Shares, without the affirmative vote of the holders of a
majority (as defined in the 1940 Act) of the Preferred Shares Outstanding at the time and present and voting on such matter, voting separately as one class. To the extent permitted under the 1940 Act, in the event that more than one series of
Preferred Shares is Outstanding, the Trust shall not effect any of the actions set forth in the preceding sentence which in the aggregate materially and adversely affects the rights and preferences set forth in the Statement of Preferences for a
series of Preferred Shares differently than such rights and preferences for any other series of Preferred Shares without the affirmative vote of the holders of at least a majority of the Preferred Shares Outstanding and present and voting on such
matter of each series materially and adversely affected (each such materially and adversely affected series voting separately as a class to the extent its rights are affected differently). The holders of the Series B Preferred Shares shall not be
entitled to vote on any matter that affects the rights or interests of only one or more other series of Preferred Shares. Unless a higher percentage is required under the Governing Documents or applicable provisions of the Delaware Statutory Trust
Act or the 1940 Act, the affirmative vote of the holders of a majority of the Outstanding Preferred Shares, including Series B Preferred Shares, voting together as a single class, will be required to approve any plan of reorganization adversely
affecting the Preferred Shares or any action requiring a vote of security holders under Section&nbsp;13(a) of the 1940 Act. For purposes of this paragraph 1(a) of Part III, the phrase &#147;vote of the holders of a majority of the Outstanding
Preferred Shares&#148; or series or series thereof (or any like phrase) shall mean, in accordance with Section&nbsp;2(a)(42) of the 1940 Act, the vote, at the annual or a special meeting of the shareholders of the Trust duly called (i)&nbsp;of
67&nbsp;percent or more of the Preferred Shares or series thereof present at such meeting, if the holders of more than 50&nbsp;percent of the Outstanding Preferred Shares or series thereof are present or represented by proxy; or (ii)&nbsp;of more
than 50&nbsp;percent of the Outstanding Preferred Shares or series thereof, whichever is less. The class vote of holders of Preferred Shares described above will in each case be in addition to a separate vote of the requisite percentage of Common
Shares and Preferred Shares, including Series B Preferred Shares, voting together as a single class, necessary to authorize the action in question. An increase in the number of authorized Preferred Shares pursuant to the Governing Documents or the
issuance of additional shares of any series of Preferred Shares (including Series B Preferred Shares) pursuant to the Governing Documents shall not in and of itself be considered to materially and adversely affect the rights and preferences of
Preferred Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding the provisions of this Part III, to the extent permitted by law, the Board of Trustees or its delegatee, without
the vote of the holders of the Series B Preferred Shares or any other capital shares of the Trust, may amend the provisions of this Statement of Preferences to resolve any inconsistency or ambiguity or to remedy any formal defect so long as the
amendment does not in the aggregate adversely affect the rights and preferences of the Series B Preferred Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. No Modification of Other Series of
Preferred Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Nothing contained in this Statement of Preferences creating the Series B Preferred Shares shall be understood to modify the rights,
obligations or privileges of any other series of the Trust&#146;s Preferred Shares Outstanding. To the extent permitted by law, the Board of Trustees, without the vote of the holders of the Series B Preferred Shares or any other shares of the Trust,
may amend the provisions of this Statement of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Preferences to resolve any inconsistency or ambiguity or to remedy any formal defect so as to negate the effect of any such modification of the rights, obligations or privileges of any other
series of the Trust&#146;s Preferred Shares Outstanding, so long as the amendment does not in the aggregate adversely affect the rights and preferences of the Series B Preferred Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, Ellsworth Growth and Income Fund Ltd. has caused this Statement of Preferences to be signed
in its name and on its behalf by a duly authorized officer, who acknowledges said instrument to be the statutory trust act of the Trust, and states that, to the best of such officer&#146;s knowledge, information and belief under penalty of perjury,
the matters and facts herein set forth with respect to approval are true in all material respects, as of June [&nbsp;&nbsp;&nbsp;&nbsp;], 2022. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attest: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="20%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title:</TD></TR>
</TABLE> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:120pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[ECF Series B Statement of Preferences Signature Page</I>] </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.(B).(II)
<SEQUENCE>3
<FILENAME>d396220dex99bii.htm
<DESCRIPTION>AMENDMENT NO. 1 TO AMENDED AND RESTATED BY-LAWS OF REGISTRANT
<TEXT>
<HTML><HEAD>
<TITLE>Amendment No. 1 to Amended and Restated By-Laws of Registrant</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDMENT NO. 1 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TO AMENDED AND RESTATED <FONT STYLE="white-space:nowrap">BY-LAWS</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ELLSWORTH GROWTH AND
INCOME FUND LTD. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Effective: August&nbsp;17, 2022 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On August&nbsp;17, 2022, the Board of Trustees of Ellsworth Growth and Income Fund Ltd. (the &#147;Fund&#148;), in accordance with the Fund&#146;s Amended and
Restated <FONT STYLE="white-space:nowrap">By-Laws</FONT> (the <FONT STYLE="white-space:nowrap">&#147;By-Laws&#148;)</FONT> and the Amended and Restated Agreement and Declaration of Trust, approved and adopted the following amendment to the <FONT
STYLE="white-space:nowrap">By-Laws,</FONT> to be effective immediately: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Article I, Section&nbsp;1.2 of the
<FONT STYLE="white-space:nowrap">By-Laws</FONT> is hereby deleted in its entirety and replaced with the following: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.2&nbsp;&nbsp;&nbsp;&nbsp;Voting. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;As provided in the Declaration, shareholders shall have no power to vote on any matter except as provided in or
pursuant to Article VI of the Declaration. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;When a quorum is present at any meeting, the vote of the holders of
a majority of the Shares cast shall decide any question brought before such meeting, unless the question is one on which, by express provision of applicable law, the Declaration, these <FONT STYLE="white-space:nowrap">By-Laws,</FONT> or applicable
contract, a different vote is required, in which case such express provision shall govern and control the decision of such question. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;All meetings of shareholders for the purpose of electing Trustees shall be held on such date and at such time as
shall be designated from time to time by the Trustees and stated in the notice of the meeting. With respect to the election of one or more Trustees, (i)&nbsp;other than a Contested Election, the affirmative vote of a plurality of the Shares present
in person or represented by proxy and entitled to vote for the election of any Trustee or Trustees shall be the act of such Shareholders with respect to the election of such Trustee or Trustees, and (ii)&nbsp;with respect to a Contested Election,
the affirmative vote of a majority of the Shares outstanding and entitled to vote for the election of any Trustee or Trustees shall be the act of such Shareholders with respect to the election of such Trustee or Trustee, in each case at any meeting
at which a quorum is present with respect to the vote on the election of such Trustee(s). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;Where a separate vote
of one or more classes or series of Shares is required on any matter: (i)&nbsp;if the vote is for the election of one or more Trustees, the vote set forth in Section&nbsp;1.2(c), above, shall apply in respect of the classes or series of Shares
entitled to vote in the election of such Trustee or Trustees; and (ii)&nbsp;if the vote is for any other matter, the affirmative vote of a majority of the Shares of such class or classes or series or series present in person or represented by proxy
and entitled to vote on such other matter, or such higher vote as may be required by the Declaration, shall be the act of the shareholders of such class or classes or series or series with respect to such other matter, in each case at any meeting at
which a quorum is present with respect to the vote on the election of such Trustee(s) or such other matter. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;&#147;Contested Election&#148; shall mean any election of Trustees in which the number of persons nominated for
election as Trustees by Shares entitled to vote for such Trustees in accordance with Section&nbsp;1.9 hereof exceeds the number of Trustees to be elected by Shares entitled to vote for such Trustees, with the determination that any election of
Trustees is a Contested Election to be made by the Secretary or other officer of the Fund prior to the time the Fund mails its initial proxy statement in connection with such election of Trustees. If, prior to the time the Fund mails its initial
proxy statement in connection with such election of Trustees, one or more persons nominated for election as a Trustee by Shares entitled to vote for such Trustee are withdrawn such that the number of persons nominated for election as Trustee by
Shares entitled to vote for such Trustee no longer exceeds the number of Trustees to be elected by Shares entitled to vote for such Trustees, such election shall not be considered a Contested Election. The determination of whether an election is a
Contested Election shall be made on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">proposal-by-proposal</FONT></FONT> basis and it is expressly acknowledged that, in the event different classes or series of Shares are entitled
to vote for different Trustees, a Contested Election may occur for some Trustee seats but not others at the same meeting of shareholders. </P>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;At any meeting of shareholders, any holder of Shares entitled to vote
thereat may vote by proxy, provided that no proxy shall be voted at any meeting unless it shall have been placed on file with the Secretary, or with such other officer or agent of the Fund as the Secretary may direct, for verification prior to the
time at which such vote shall be taken. Pursuant to a resolution of a majority of the Trustees, proxies may be solicited in the name of one or more Trustees or one or more of the officers or employees of the Trust or its investment adviser, with
power of substitution. Only shareholders of record shall be entitled to vote. Each full Share shall be entitled to one vote and each fractional Share shall be entitled to a vote equal to its fraction of a full Share. When any Share is held jointly
by several persons, any one of them may vote at any meeting in person or by proxy in respect of such Share, but if more than one of them shall be present at such meeting in person or by proxy, and such joint owners or their proxies so present
disagree as to any vote to be cast, such vote shall not be received in respect of such Share. A proxy purporting to be given by or on behalf of a shareholder of record on the record date for a meeting shall be deemed valid unless challenged at or
prior to its exercise, and the burden of proving invalidity shall rest on the challenger. If the holder of any such Share is a minor or a person of unsound mind, and subject to guardianship or to the legal control of any other person as regards the
charge or management of such Share, he may vote by his guardian or such other person appointed or having such control, and such vote may be given in person or by proxy. The Trustees shall have the authority to make and modify from time to time
regulations regarding the validity of proxies. In addition to signed proxies, such regulations may authorize facsimile, telephonic, Internet and other methods of appointing a proxy that are subject to such supervision by or under the direction of
the Trustees as the Trustees shall determine. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Article I, Section&nbsp;1.11 of the Bylaws is hereby deleted in its entirety and replaced
with the following: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.11&nbsp;&nbsp;&nbsp;&nbsp;Quorum. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Subject to a resolution of the Trustees specifying a greater or a lesser quorum requirement for the transaction of any item of business that
properly comes before any meeting of shareholders, (a)&nbsp;the holders of <FONT STYLE="white-space:nowrap">one-third</FONT> of the outstanding Shares of the Fund on the record date present in person or by proxy shall constitute a quorum at any
meeting of the shareholders for purposes of conducting business on which a vote of all shareholders of the Fund is being taken, (b)&nbsp;the holders of <FONT STYLE="white-space:nowrap">one-third</FONT> of the outstanding Shares of a class or classes
on the record date present in person or by proxy shall constitute a quorum at any meeting of the shareholders of such class or classes for purposes of conducting business on which a vote of shareholders of such class or classes is being taken or
(c)&nbsp;the holders of <FONT STYLE="white-space:nowrap">one-third</FONT> of the outstanding Shares of a series or series on the record date present in person or by proxy shall constitute a quorum at any meeting of the shareholders of such series or
series for purposes of conducting business on which a vote of shareholders of such series or series is being taken. Shares underlying a proxy as to which a broker or other intermediary states its absence of authority to vote with respect to one or
more matters shall be treated as present for purposes of establishing a quorum for taking action on any such matter only to the extent so determined by the Trustees at or prior to the meeting of shareholders at which such matter is to be considered.
</P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>cik0000793040-20220824.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 25-August-2022 [04:21:21] {AM}-->
<schema targetNamespace="http://www.gabelli.com/20220824" elementFormDefault="qualified" xmlns:cik0000793040="http://www.gabelli.com/20220824" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:cef="http://xbrl.sec.gov/cef/2022">
<annotation>
<appinfo>
<link:linkbaseRef xlink:type="simple" xlink:href="cik0000793040-20220824_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="cik0000793040-20220824_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="cik0000793040-20220824_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
</appinfo>
</annotation>
<import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
<import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
<import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
<import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
<import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
<import namespace="http://xbrl.sec.gov/cef/2022" schemaLocation="https://xbrl.sec.gov/cef/2022/cef-2022.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>cik0000793040-20220824_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 25-August-2022 [04:21:21] {AM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
<roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2022/cef-2022.xsd#SecurityOnly" roleURI="http://xbrl.sec.gov/cef/role/SecurityOnly" />
<roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2022/cef-2022.xsd#RiskOnly" roleURI="http://xbrl.sec.gov/cef/role/RiskOnly" />
<arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
<definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/SecurityOnly">
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2022/cef-2022.xsd#cef_AllSecuritiesMember" xlink:label="loc_cef_AllSecuritiesMember_205" />
</definitionLink>
<definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/RiskOnly">
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2022/cef-2022.xsd#cef_AllRisksMember" xlink:label="loc_cef_AllRisksMember_207" />
</definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>cik0000793040-20220824_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 25-August-2022 [04:21:21] {AM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
<roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
<labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link" />
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>cik0000793040-20220824_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 25-August-2022 [04:21:21] {AM}-->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2022/cef-2022.xsd#N2" roleURI="http://xbrl.sec.gov/cef/role/N2" />
<presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2">
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2022/cef-2022.xsd#cef_AllSecuritiesMember" xlink:label="loc_cef_AllSecuritiesMember_205" />
<loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2022/cef-2022.xsd#cef_AllRisksMember" xlink:label="loc_cef_AllRisksMember_207" />
</presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140479093828432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>N-2<br></strong></div></th>
<th class="th"><div>Aug. 24, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000793040<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">POS EX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Ellsworth Growth and Income Fund Ltd.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One Corporate Center<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Rye<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10580-1422<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">422-3554<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_NoSubstantiveChanges462c', window );">No Substantive Changes, 462(c)</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ExhibitsOnly462d', window );">Exhibits Only, 462(d)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One Corporate Center<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Rye<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10580-1422<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">James A. Dinsmore<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ExhibitsOnly462d">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 462<br> -Subsection d<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ExhibitsOnly462d</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_NoSubstantiveChanges462c">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 462<br> -Subsection c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_NoSubstantiveChanges462c</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>d396220dposex_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cik0000793040-20220824.xsd" xlink:type="simple"/>
    <context id="P08_24_2022To08_24_2022">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000793040</identifier>
        </entity>
        <period>
            <startDate>2022-08-24</startDate>
            <endDate>2022-08-24</endDate>
        </period>
    </context>
    <context id="P08_24_2022To08_24_2022_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000793040</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-24</startDate>
            <endDate>2022-08-24</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="P08_24_2022To08_24_2022">0000793040</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="P08_24_2022To08_24_2022">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="P08_24_2022To08_24_2022">POS EX</dei:DocumentType>
    <dei:EntityWellKnownSeasonedIssuer contextRef="P08_24_2022To08_24_2022" id="hidden55199683">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityRegistrantName contextRef="P08_24_2022To08_24_2022">Ellsworth Growth and Income Fund Ltd.</dei:EntityRegistrantName>
    <dei:EntityAddressAddressLine1 contextRef="P08_24_2022To08_24_2022">One Corporate Center</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="P08_24_2022To08_24_2022">Rye</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="P08_24_2022To08_24_2022">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="P08_24_2022To08_24_2022">10580-1422</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="P08_24_2022To08_24_2022">800</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="P08_24_2022To08_24_2022">422-3554</dei:LocalPhoneNumber>
    <dei:ContactPersonnelName contextRef="P08_24_2022To08_24_2022_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">James A. Dinsmore</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1 contextRef="P08_24_2022To08_24_2022_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">One Corporate Center</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="P08_24_2022To08_24_2022_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">Rye</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="P08_24_2022To08_24_2022_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="P08_24_2022To08_24_2022_BusinessContactMemberdeiEntityAddressesAddressTypeAxis">10580-1422</dei:EntityAddressPostalZipCode>
    <dei:NoSubstantiveChanges462c contextRef="P08_24_2022To08_24_2022">false</dei:NoSubstantiveChanges462c>
    <dei:ExhibitsOnly462d contextRef="P08_24_2022To08_24_2022">true</dei:ExhibitsOnly462d>
    <dei:EntityEmergingGrowthCompany contextRef="P08_24_2022To08_24_2022">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M40D5!B@W*A(5UW:*+2?=Z'6F]P]WC]I"Z]R38N_AC6PY!AP_9_D#4$L#!!0
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ML;S63AI_YHOA/UY_ 5!+ 0(4 Q0    ( %&F&%4'04UB@0   +$    0
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M/0P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " !1IAA5EXJ[',     3 @
M"P              @ $9#P  7W)E;',O+G)E;'-02P$"% ,4    " !1IAA5
MMD)7)C(!   @ @  #P              @ $"$   >&PO=V]R:V)O;VLN>&UL
M4$L! A0#%     @ 4:88520>FZ*M    ^ $  !H              ( !81$
M 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ 4:885660
M>9(9 0  SP,  !,              ( !1A(  %M#;VYT96YT7U1Y<&5S72YX
8;6Q02P4&      D "0 ^ @  D!,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>15</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d396220dposex.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995470 - Disclosure - N-2</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cef/role/N2</Role>
      <ShortName>N-2</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="POS EX" original="d396220dposex.htm">d396220dposex.htm</File>
    <File>cik0000793040-20220824.xsd</File>
    <File>cik0000793040-20220824_def.xml</File>
    <File>cik0000793040-20220824_lab.xml</File>
    <File>cik0000793040-20220824_pre.xml</File>
    <File>d396220dex99av.htm</File>
    <File>d396220dex99bii.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="19">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d396220dposex.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "contextCount": 2,
   "dts": {
    "definitionLink": {
     "local": [
      "cik0000793040-20220824_def.xml"
     ]
    },
    "inline": {
     "local": [
      "d396220dposex.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cik0000793040-20220824_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cik0000793040-20220824_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cik0000793040-20220824.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/2006/xbrldi-2006.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/cef/2022/cef-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022_lab.xsd"
     ]
    }
   },
   "elementCount": 189,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 4,
    "total": 4
   },
   "keyCustom": 0,
   "keyStandard": 15,
   "memberCustom": 0,
   "memberStandard": 1,
   "nsprefix": "cik0000793040",
   "nsuri": "http://www.gabelli.com/20220824",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d396220dposex.htm",
      "contextRef": "P08_24_2022To08_24_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "true",
     "longName": "995470 - Disclosure - N-2",
     "role": "http://xbrl.sec.gov/cef/role/N2",
     "shortName": "N-2",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d396220dposex.htm",
      "contextRef": "P08_24_2022To08_24_2022",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 1,
   "tag": {
    "cef_AcquiredFundFeesAndExpensesNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses, Note [Text Block]"
       }
      }
     },
     "localname": "AcquiredFundFeesAndExpensesNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_AcquiredFundFeesAndExpensesPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses [Percent]"
       }
      }
     },
     "localname": "AcquiredFundFeesAndExpensesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_AcquiredFundFeesEstimatedNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees Estimated, Note [Text Block]"
       }
      }
     },
     "localname": "AcquiredFundFeesEstimatedNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_AcquiredFundIncentiveAllocationNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Incentive Allocation, Note [Text Block]"
       }
      }
     },
     "localname": "AcquiredFundIncentiveAllocationNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_AcquiredFundTotalAnnualExpensesNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Total Annual Expenses, Note [Text Block]"
       }
      }
     },
     "localname": "AcquiredFundTotalAnnualExpensesNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_AllRisksMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Risks:"
       }
      }
     },
     "localname": "AllRisksMember",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "domainItemType"
    },
    "cef_AllSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Securities:"
       }
      }
     },
     "localname": "AllSecuritiesMember",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "domainItemType"
    },
    "cef_AnnualCoverageReturnRatePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Coverage Return Rate [Percent]"
       }
      }
     },
     "localname": "AnnualCoverageReturnRatePercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_AnnualDividendPayment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment"
       }
      }
     },
     "localname": "AnnualDividendPayment",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_AnnualDividendPaymentCurrent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Current"
       }
      }
     },
     "localname": "AnnualDividendPaymentCurrent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_AnnualDividendPaymentInitial": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Initial"
       }
      }
     },
     "localname": "AnnualDividendPaymentInitial",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_AnnualExpensesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Expenses [Table Text Block]"
       }
      }
     },
     "localname": "AnnualExpensesTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_AnnualInterestRateCurrentPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Current [Percent]"
       }
      }
     },
     "localname": "AnnualInterestRateCurrentPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_AnnualInterestRateInitialPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Initial [Percent]"
       }
      }
     },
     "localname": "AnnualInterestRateInitialPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_AnnualInterestRatePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate [Percent]"
       }
      }
     },
     "localname": "AnnualInterestRatePercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_BasisOfTransactionFeesNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Transaction Fees, Note [Text Block]"
       }
      }
     },
     "localname": "BasisOfTransactionFeesNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_BdcFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "BDC File Number"
       }
      }
     },
     "localname": "BdcFileNumber",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "cef_BusinessDevelopmentCompanyFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Development Company [Flag]"
       }
      }
     },
     "localname": "BusinessDevelopmentCompanyFlag",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock, Long-Term Debt, and Other Securities [Abstract]"
       }
      }
     },
     "localname": "CapitalStockLongTermDebtAndOtherSecuritiesAbstract",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_CapitalStockTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock [Table Text Block]"
       }
      }
     },
     "localname": "CapitalStockTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_DistributionServicingFeesPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distribution/Servicing Fees [Percent]"
       }
      }
     },
     "localname": "DistributionServicingFeesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_DistributionsMayReducePrincipalTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distributions May Reduce Principal [Text Block]"
       }
      }
     },
     "localname": "DistributionsMayReducePrincipalTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_DividendAndInterestExpensesOnShortSalesPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend and Interest Expenses on Short Sales [Percent]"
       }
      }
     },
     "localname": "DividendAndInterestExpensesOnShortSalesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_DividendExpenseOnPreferredSharesPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Expenses on Preferred Shares [Percent]"
       }
      }
     },
     "localname": "DividendExpenseOnPreferredSharesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_DividendReinvestmentAndCashPurchaseFees": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Reinvestment and Cash Purchase Fees"
       }
      }
     },
     "localname": "DividendReinvestmentAndCashPurchaseFees",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_EffectsOfLeveragePurposeTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage, Purpose [Text Block]"
       }
      }
     },
     "localname": "EffectsOfLeveragePurposeTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_EffectsOfLeverageTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Table Text Block]"
       }
      }
     },
     "localname": "EffectsOfLeverageTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_EffectsOfLeverageTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Text Block]"
       }
      }
     },
     "localname": "EffectsOfLeverageTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_ExpenseExampleTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example [Table Text Block]"
       }
      }
     },
     "localname": "ExpenseExampleTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_ExpenseExampleYear01": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Year 01"
       }
      }
     },
     "localname": "ExpenseExampleYear01",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_ExpenseExampleYears1to10": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 10"
       }
      }
     },
     "localname": "ExpenseExampleYears1to10",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_ExpenseExampleYears1to3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 3"
       }
      }
     },
     "localname": "ExpenseExampleYears1to3",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_ExpenseExampleYears1to5": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 5"
       }
      }
     },
     "localname": "ExpenseExampleYears1to5",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_FeeTableAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Table [Abstract]"
       }
      }
     },
     "localname": "FeeTableAbstract",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_FinancialHighlightsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Highlights [Abstract]"
       }
      }
     },
     "localname": "FinancialHighlightsAbstract",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_GeneralDescriptionOfRegistrantAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Description of Registrant [Abstract]"
       }
      }
     },
     "localname": "GeneralDescriptionOfRegistrantAbstract",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_HighestPriceOrBid": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid"
       }
      }
     },
     "localname": "HighestPriceOrBid",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_HighestPriceOrBidNav": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, NAV"
       }
      }
     },
     "localname": "HighestPriceOrBidNav",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_HighestPriceOrBidPremiumDiscountToNavPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "localname": "HighestPriceOrBidPremiumDiscountToNavPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_IncentiveAllocationMaximumPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Maximum [Percent]"
       }
      }
     },
     "localname": "IncentiveAllocationMaximumPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_IncentiveAllocationMinimumPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Minimum [Percent]"
       }
      }
     },
     "localname": "IncentiveAllocationMinimumPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_IncentiveAllocationPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation [Percent]"
       }
      }
     },
     "localname": "IncentiveAllocationPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_IncentiveFeesPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Fees [Percent]"
       }
      }
     },
     "localname": "IncentiveFeesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_InterestExpensesOnBorrowingsPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Expenses on Borrowings [Percent]"
       }
      }
     },
     "localname": "InterestExpensesOnBorrowingsPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_IntervalFundFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interval Fund [Flag]"
       }
      }
     },
     "localname": "IntervalFundFlag",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "cef_InvestmentObjectivesAndPracticesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Objectives and Practices [Text Block]"
       }
      }
     },
     "localname": "InvestmentObjectivesAndPracticesTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_LatestNav": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest NAV"
       }
      }
     },
     "localname": "LatestNav",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_LatestPremiumDiscountToNavPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "localname": "LatestPremiumDiscountToNavPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_LatestSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest Share Price"
       }
      }
     },
     "localname": "LatestSharePrice",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_LoanServicingFeesPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan Servicing Fees [Percent]"
       }
      }
     },
     "localname": "LoanServicingFeesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_LongTermDebtDividendsAndCovenantsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Dividends and Covenants [Text Block]"
       }
      }
     },
     "localname": "LongTermDebtDividendsAndCovenantsTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_LongTermDebtIssuanceAndSubstitutionTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Issuance and Substitution [Text Block]"
       }
      }
     },
     "localname": "LongTermDebtIssuanceAndSubstitutionTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_LongTermDebtPrincipal": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Principal"
       }
      }
     },
     "localname": "LongTermDebtPrincipal",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_LongTermDebtRightsLimitedByOtherSecuritiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "localname": "LongTermDebtRightsLimitedByOtherSecuritiesTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_LongTermDebtStructuringTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Structuring [Text Block]"
       }
      }
     },
     "localname": "LongTermDebtStructuringTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_LongTermDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt [Table Text Block]"
       }
      }
     },
     "localname": "LongTermDebtTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_LongTermDebtTitleTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Title [Text Block]"
       }
      }
     },
     "localname": "LongTermDebtTitleTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_LowestPriceOrBid": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid"
       }
      }
     },
     "localname": "LowestPriceOrBid",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_LowestPriceOrBidNav": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, NAV"
       }
      }
     },
     "localname": "LowestPriceOrBidNav",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_LowestPriceOrBidPremiumDiscountToNavPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "localname": "LowestPriceOrBidPremiumDiscountToNavPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_ManagementFeeNotBasedOnNetAssetsNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fee not based on Net Assets, Note [Text Block]"
       }
      }
     },
     "localname": "ManagementFeeNotBasedOnNetAssetsNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_ManagementFeesPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fees [Percent]"
       }
      }
     },
     "localname": "ManagementFeesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_NetExpenseOverAssetsPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Expense over Assets [Percent]"
       }
      }
     },
     "localname": "NetExpenseOverAssetsPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_NewCefOrBdcRegistrantFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "New CEF or BDC Registrant [Flag]"
       }
      }
     },
     "localname": "NewCefOrBdcRegistrantFlag",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "cef_NoPublicTradingTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Public Trading [Text Block]"
       }
      }
     },
     "localname": "NoPublicTradingTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_NoTradingHistoryTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading History [Text Block]"
       }
      }
     },
     "localname": "NoTradingHistoryTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OtherAnnualExpense1Percent": {
     "auth_ref": [],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "order": 1.0,
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 1 [Percent]"
       }
      }
     },
     "localname": "OtherAnnualExpense1Percent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherAnnualExpense2Percent": {
     "auth_ref": [],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "order": 2.0,
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 2 [Percent]"
       }
      }
     },
     "localname": "OtherAnnualExpense2Percent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherAnnualExpense3Percent": {
     "auth_ref": [],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "order": 3.0,
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 3 [Percent]"
       }
      }
     },
     "localname": "OtherAnnualExpense3Percent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherAnnualExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Abstract]"
       }
      }
     },
     "localname": "OtherAnnualExpensesAbstract",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_OtherAnnualExpensesPercent": {
     "auth_ref": [],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Percent]"
       }
      }
     },
     "localname": "OtherAnnualExpensesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherExpensesNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Expenses, Note [Text Block]"
       }
      }
     },
     "localname": "OtherExpensesNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OtherFeederFundExpensesPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Feeder Fund Expenses [Percent]"
       }
      }
     },
     "localname": "OtherFeederFundExpensesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherMasterFundExpensesPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Master Fund Expenses [Percent]"
       }
      }
     },
     "localname": "OtherMasterFundExpensesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherSecuritiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Securities [Table Text Block]"
       }
      }
     },
     "localname": "OtherSecuritiesTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OtherSecurityDescriptionTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Description [Text Block]"
       }
      }
     },
     "localname": "OtherSecurityDescriptionTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OtherSecurityTitleTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Title [Text Block]"
       }
      }
     },
     "localname": "OtherSecurityTitleTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OtherTransactionExpense1Percent": {
     "auth_ref": [],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "order": 1.0,
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 1 [Percent]"
       }
      }
     },
     "localname": "OtherTransactionExpense1Percent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherTransactionExpense2Percent": {
     "auth_ref": [],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "order": 2.0,
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 2 [Percent]"
       }
      }
     },
     "localname": "OtherTransactionExpense2Percent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherTransactionExpense3Percent": {
     "auth_ref": [],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "order": 3.0,
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 3 [Percent]"
       }
      }
     },
     "localname": "OtherTransactionExpense3Percent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherTransactionExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Abstract]"
       }
      }
     },
     "localname": "OtherTransactionExpensesAbstract",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_OtherTransactionExpensesPercent": {
     "auth_ref": [],
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Percent]"
       }
      }
     },
     "localname": "OtherTransactionExpensesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherTransactionFeesBasisMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum"
       }
      }
     },
     "localname": "OtherTransactionFeesBasisMaximum",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_OtherTransactionFeesBasisMaximumPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum [Percent]"
       }
      }
     },
     "localname": "OtherTransactionFeesBasisMaximumPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_OtherTransactionFeesBasisNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Note [Text Block]"
       }
      }
     },
     "localname": "OtherTransactionFeesBasisNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OtherTransactionFeesNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees, Note [Text Block]"
       }
      }
     },
     "localname": "OtherTransactionFeesNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OutstandingSecuritiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Securities [Table Text Block]"
       }
      }
     },
     "localname": "OutstandingSecuritiesTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_OutstandingSecurityAuthorizedShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Authorized [Shares]"
       }
      }
     },
     "localname": "OutstandingSecurityAuthorizedShares",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "sharesItemType"
    },
    "cef_OutstandingSecurityHeldShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Held [Shares]"
       }
      }
     },
     "localname": "OutstandingSecurityHeldShares",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "sharesItemType"
    },
    "cef_OutstandingSecurityNotHeldShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Not Held [Shares]"
       }
      }
     },
     "localname": "OutstandingSecurityNotHeldShares",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "sharesItemType"
    },
    "cef_OutstandingSecurityTitleTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Title [Text Block]"
       }
      }
     },
     "localname": "OutstandingSecurityTitleTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_PreferredStockRestrictionsArrearageTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Arrearage [Text Block]"
       }
      }
     },
     "localname": "PreferredStockRestrictionsArrearageTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_PreferredStockRestrictionsOtherTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Other [Text Block]"
       }
      }
     },
     "localname": "PreferredStockRestrictionsOtherTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_PrimaryShelfFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf [Flag]"
       }
      }
     },
     "localname": "PrimaryShelfFlag",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "cef_PrimaryShelfQualifiedFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf Qualified [Flag]"
       }
      }
     },
     "localname": "PrimaryShelfQualifiedFlag",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "cef_ProspectusLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus [Line Items]"
       }
      }
     },
     "localname": "ProspectusLineItems",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "xbrltype": "stringItemType"
    },
    "cef_ProspectusTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus:"
       }
      }
     },
     "localname": "ProspectusTable",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_PurposeOfFeeTableNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purpose of Fee Table , Note [Text Block]"
       }
      }
     },
     "localname": "PurposeOfFeeTableNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_RegisteredClosedEndFundFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registered Closed-End Fund [Flag]"
       }
      }
     },
     "localname": "RegisteredClosedEndFundFlag",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "cef_ReturnAtMinusFivePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Five [Percent]"
       }
      }
     },
     "localname": "ReturnAtMinusFivePercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_ReturnAtMinusTenPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Ten [Percent]"
       }
      }
     },
     "localname": "ReturnAtMinusTenPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_ReturnAtPlusFivePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Five [Percent]"
       }
      }
     },
     "localname": "ReturnAtPlusFivePercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_ReturnAtPlusTenPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Ten [Percent]"
       }
      }
     },
     "localname": "ReturnAtPlusTenPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_ReturnAtZeroPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Zero [Percent]"
       }
      }
     },
     "localname": "ReturnAtZeroPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_RightsLimitedByOtherSecuritiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "localname": "RightsLimitedByOtherSecuritiesTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_RightsSubjectToOtherThanMajorityVoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Subject to Other than Majority Vote [Text Block]"
       }
      }
     },
     "localname": "RightsSubjectToOtherThanMajorityVoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_RiskAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Axis]"
       }
      }
     },
     "localname": "RiskAxis",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_RiskFactorsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk Factors [Table Text Block]"
       }
      }
     },
     "localname": "RiskFactorsTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_RiskTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Text Block]"
       }
      }
     },
     "localname": "RiskTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SalesLoadPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales Load [Percent]"
       }
      }
     },
     "localname": "SalesLoadPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_SecurityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security [Axis]"
       }
      }
     },
     "localname": "SecurityAxis",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "cef_SecurityDividendsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Dividends [Text Block]"
       }
      }
     },
     "localname": "SecurityDividendsTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SecurityLiabilitiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liabilities [Text Block]"
       }
      }
     },
     "localname": "SecurityLiabilitiesTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SecurityLiquidationRightsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liquidation Rights [Text Block]"
       }
      }
     },
     "localname": "SecurityLiquidationRightsTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SecurityObligationsOfOwnershipTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Obligations of Ownership [Text Block]"
       }
      }
     },
     "localname": "SecurityObligationsOfOwnershipTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SecurityPreemptiveAndOtherRightsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Preemptive and Other Rights [Text Block]"
       }
      }
     },
     "localname": "SecurityPreemptiveAndOtherRightsTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SecurityTitleTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Title [Text Block]"
       }
      }
     },
     "localname": "SecurityTitleTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SecurityVotingRightsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Voting Rights [Text Block]"
       }
      }
     },
     "localname": "SecurityVotingRightsTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SeniorSecuritiesAmount": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Amount"
       }
      }
     },
     "localname": "SeniorSecuritiesAmount",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_SeniorSecuritiesAverageMarketValuePerUnit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Average Market Value per Unit"
       }
      }
     },
     "localname": "SeniorSecuritiesAverageMarketValuePerUnit",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_SeniorSecuritiesAveragingMethodNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Averaging Method, Note [Text Block]"
       }
      }
     },
     "localname": "SeniorSecuritiesAveragingMethodNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SeniorSecuritiesCoveragePerUnit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Coverage per Unit"
       }
      }
     },
     "localname": "SeniorSecuritiesCoveragePerUnit",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_SeniorSecuritiesHeadingsNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Headings, Note [Text Block]"
       }
      }
     },
     "localname": "SeniorSecuritiesHeadingsNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SeniorSecuritiesHighlightsAnnualizedNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Annualized, Note [Text Block]"
       }
      }
     },
     "localname": "SeniorSecuritiesHighlightsAnnualizedNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SeniorSecuritiesHighlightsAuditedNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Audited, Note [Text Block]"
       }
      }
     },
     "localname": "SeniorSecuritiesHighlightsAuditedNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SeniorSecuritiesInvoluntaryLiquidatingPreferencePerUnit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Involuntary Liquidating Preference per Unit"
       }
      }
     },
     "localname": "SeniorSecuritiesInvoluntaryLiquidatingPreferencePerUnit",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "cef_SeniorSecuritiesNoteTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities, Note [Text Block]"
       }
      }
     },
     "localname": "SeniorSecuritiesNoteTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SeniorSecuritiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities [Table Text Block]"
       }
      }
     },
     "localname": "SeniorSecuritiesTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SharePriceTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price [Table Text Block]"
       }
      }
     },
     "localname": "SharePriceTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_SharePricesNotActualTransactionsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Prices Not Actual Transactions [Text Block]"
       }
      }
     },
     "localname": "SharePricesNotActualTransactionsTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_ShareholderTransactionExpensesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholder Transaction Expenses [Table Text Block]"
       }
      }
     },
     "localname": "ShareholderTransactionExpensesTableTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_TotalAnnualExpensesPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Annual Expenses [Percent]"
       }
      }
     },
     "localname": "TotalAnnualExpensesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_UnderwritersCompensationPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underwriters Compensation [Percent]"
       }
      }
     },
     "localname": "UnderwritersCompensationPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_WaiversAndReimbursementsOfFeesPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Waivers and Reimbursements of Fees [Percent]"
       }
      }
     },
     "localname": "WaiversAndReimbursementsOfFeesPercent",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "percentItemType"
    },
    "cef_WarrantsOrRightsCalledAmount": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Amount"
       }
      }
     },
     "localname": "WarrantsOrRightsCalledAmount",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cef_WarrantsOrRightsCalledPeriodDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Period [Date]"
       }
      }
     },
     "localname": "WarrantsOrRightsCalledPeriodDate",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "dateItemType"
    },
    "cef_WarrantsOrRightsCalledTitleTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Title"
       }
      }
     },
     "localname": "WarrantsOrRightsCalledTitleTextBlock",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cef_WarrantsOrRightsExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Exercise Price"
       }
      }
     },
     "localname": "WarrantsOrRightsExercisePrice",
     "nsuri": "http://xbrl.sec.gov/cef/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "perShareItemType"
    },
    "dei_AdditionalSecurities462b": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "localname": "AdditionalSecurities462b",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "localname": "AdditionalSecurities462bFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "localname": "AdditionalSecuritiesEffective413b",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AddressTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.",
        "label": "Address Type [Domain]"
       }
      }
     },
     "localname": "AddressTypeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings.",
        "label": "Approximate Date of Commencement of Proposed Sale to Public"
       }
      }
     },
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "dateOrAsapItemType"
    },
    "dei_BusinessContactMember": {
     "auth_ref": [
      "r2",
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business contact for the entity",
        "label": "Business Contact [Member]"
       }
      }
     },
     "localname": "BusinessContactMember",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of contact personnel",
        "label": "Contact Personnel Name"
       }
      }
     },
     "localname": "ContactPersonnelName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DelayedOrContinuousOffering": {
     "auth_ref": [
      "r4",
      "r5",
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "localname": "DelayedOrContinuousOffering",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "auth_ref": [
      "r4",
      "r5",
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EffectiveAfter60Days486a": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "localname": "EffectiveAfter60Days486a",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveOnDate486a": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "localname": "EffectiveOnDate486a",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_EffectiveOnDate486b": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "localname": "EffectiveOnDate486b",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_EffectiveOnSetDate486a": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "localname": "EffectiveOnSetDate486a",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveOnSetDate486b": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "localname": "EffectiveOnSetDate486b",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveUponFiling462e": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "localname": "EffectiveUponFiling462e",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveUponFiling486b": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "localname": "EffectiveUponFiling486b",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "localname": "EffectiveWhenDeclaredSection8c",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Addresses, Address Type [Axis]"
       }
      }
     },
     "localname": "EntityAddressesAddressTypeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Securities Act File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityInvCompanyType": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product).",
        "label": "Entity Inv Company Type"
       }
      }
     },
     "localname": "EntityInvCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "invCompanyType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_ExhibitsOnly462d": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "localname": "ExhibitsOnly462d",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "localname": "ExhibitsOnly462dFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_InvestmentCompanyActFileNumber": {
     "auth_ref": [
      "r5",
      "r6",
      "r7",
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "localname": "InvestmentCompanyActFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_InvestmentCompanyActRegistration": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "localname": "InvestmentCompanyActRegistration",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "localname": "InvestmentCompanyRegistrationAmendment",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "sequenceNumberItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "auth_ref": [
      "r5",
      "r6",
      "r7",
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "localname": "NewEffectiveDateForPreviousFiling",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_NoSubstantiveChanges462c": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "localname": "NoSubstantiveChanges462c",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "localname": "NoSubstantiveChanges462cFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_PostEffectiveAmendment": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "localname": "PostEffectiveAmendment",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PostEffectiveAmendmentNumber": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective.",
        "label": "Post-Effective Amendment Number"
       }
      }
     },
     "localname": "PostEffectiveAmendmentNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "sequenceNumberItemType"
    },
    "dei_PreEffectiveAmendment": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "localname": "PreEffectiveAmendment",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreEffectiveAmendmentNumber": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective.",
        "label": "Pre-Effective Amendment Number"
       }
      }
     },
     "localname": "PreEffectiveAmendmentNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "xbrltype": "sequenceNumberItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r10": {
   "Name": "Investment Company Act",
   "Number": "270",
   "Publisher": "SEC"
  },
  "r11": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "313"
  },
  "r12": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r13": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "413",
   "Subsection": "b"
  },
  "r14": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "462",
   "Subsection": "b"
  },
  "r15": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "462",
   "Subsection": "c"
  },
  "r16": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "462",
   "Subsection": "d"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "462",
   "Subsection": "e"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "486",
   "Subsection": "a"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "486",
   "Subsection": "b"
  },
  "r2": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r20": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r21": {
   "Name": "Securities Act",
   "Publisher": "SEC",
   "Section": "8",
   "Subsection": "c"
  },
  "r3": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r4": {
   "Name": "Form F-3",
   "Publisher": "SEC"
  },
  "r5": {
   "Name": "Form N-2",
   "Publisher": "SEC"
  },
  "r6": {
   "Name": "Form N-3",
   "Publisher": "SEC"
  },
  "r7": {
   "Name": "Form N-4",
   "Publisher": "SEC"
  },
  "r8": {
   "Name": "Form N-6",
   "Publisher": "SEC"
  },
  "r9": {
   "Name": "Form S-3",
   "Publisher": "SEC"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001193125-22-228841-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-22-228841-xbrl.zip
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MCJYPJH]N%^X"#JYOYP#LB_TG2[=7@Y-N!^IQ23=TNWB=--IZN/@-4$L#!!0
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MS\<(1"9S)@9M7)H^V<9[NZLK.VN$G(  E1K(4>\1'1YWSM#-03=!':%-*C)
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M,;H*5Q@-LB>.R5FBHXW#4TCLJN0Z^P6;JN+XF\5"JCM.U=9G7<24!(R:^EB
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M'ZG=?J_#;8+SSG>D8S=/I)@&F3=?+/OSKG3&-N5&:10W2QZ[&:^3V9#%J\I
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M6[^<PRY;US^?6*:L/+ZVOG^U&@>MEL(CC&=B'8T%R:^'UJAVX!>Y-:#( \[
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M?=,H9AR*Q,,:T"KSHQZI,MRWQX*X>7CKVKR <S _8:%D'BUB'LU:F4G0H?)
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M,$8I&>0N9%*\%0BU]VH[JXZ@5P.4,ZQ>]_8PTFKL5&SFZ='S]?3\LO,F]!?
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M6D?PVE#<L@GR(4PD5\CITSK0&'&!;^$#3PUSL.E%J ZCS,(;3AS4-(VE5T*
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M;#:OJRBJDNR5>[9RSXHANA/9<**^@SKYB)JI6(AVJWY4X696#DMK.:RIL_+
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MBELV<=B1O&=O@CWN-\OUR5+TRUQ5$3LJR-]FW2")9] !7:V4]F<6#IZ?H*J
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M,C0N>'-D4$L! A0 %     @ <5 ^5?-&C]GL 0  PP4  !X
M ( !]P(  &-I:S P,# W.3,P-# M,C R,C X,C1?9&5F+GAM;%!+ 0(4 !0
M   ( '%0/E71W\U^I $  ,(&   >              "  1\%  !C:6LP,# P
M-SDS,#0P+3(P,C(P.#(T7VQA8BYX;6Q02P$"%  4    " !Q4#Y5\>L>*Z0!
M  #; P  '@              @ '_!@  8VEK,# P,#<Y,S T,"TR,#(R,#@R
M-%]P<F4N>&UL4$L! A0 %     @ <5 ^58J2Q&&^-@  'AD! !(
M     ( !WP@  &0S.38R,C!D97@Y.6%V+FAT;5!+ 0(4 !0    ( '%0/E5%
MO?06T L   \K   3              "  <T_  !D,SDV,C(P9&5X.3EB:6DN
M:'1M4$L! A0 %     @ <5 ^52Z"X6J /P  I!8" !$              ( !
KSDL  &0S.38R,C!D<&]S97@N:'1M4$L%!@     '  < [ $  'V+      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
